Calls for Papers

Audiology and Neurotology

Management of Temporal Bone Paragangliomas

For the upcoming collection, “Management of Temporal Bone Paragangliomas”, Audiology and Neurotology encourages researchers and clinicians to take part in our Call for Papers (CfP) on paragangliomas of the head and neck, which are rare hypervascular tumors of the neural crest originating mainly from parasympathetic paragangliomas. These rare tumors ( <0.5% of all head and neck tumors) can occur at any age but tend to peak between the fourth and seventh decades, with a female preponderance.

Paragangliomas of the head and neck tend to grow slowly; however, they often involve critical surrounding structures (bone, vessels, and nerves) due to their invasive nature. Depending on the extent of growth, these tumors can cause serious complications as consequences of cranial nerve involvement (dysphagia, dysphonia, and cranial nerve palsy).

Surgery is the most effective therapy - the other options are "wait and scan" and radiotherapy, but the effectiveness of radiotherapy remains a matter of debate. Surgical approaches and techniques have also evolved over the past 3 decades, and tumors once considered inoperable can now be safely removed, provided specific expertise in lateral skull base and head and neck surgery is available.

This pathology represents an ongoing challenge for otolaryngologists both surgically and clinically. Early diagnosis and familial genetic study could result in better treatment with fewer or no post-surgical sequelae.

The purpose of this CfP is to stimulate discussion in different areas of the field in order to improve treatment outcomes and the quality of life of patients. We welcome original research, reviews, case studies, and brief reports.

Please select the option “Call for Papers: Management of Temporal Bone Paragangliomas” when submitting your manuscript and mention this Call for Papers in your cover letter.

Audiology and Neurotology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Folia Phoniatrica et Logopaedica

Melody and Rhythmicity in Vocal Patterns of Prelexical Infants

Folia Phoniatrica et Logopaedica is issuing a Call for Papers for its next special issue on the “Melody and Rhythmicity in Vocal Patterns of Prelexical Infants”.

This special issue aims to bring together recent innovative research in the field of infant vocal development and to understand their implications for a better understanding of the earliest vocal roots of language. This knowledge is crucial for the early identification of infants whose language development is at risk, as well as indispensable for therapists to design individually optimized treatment for clinical practice.

We welcome original research, reviews, and case reports. If you have any questions pertaining to suitability for the Call for Papers, you can contact Prof. Michael Robb, Editor-in-Chief of Folia Phoniatrica et Logopaedica by email ([email protected]). Please use ‘Infant Vocalization Special Issue’ in the subject line.

The submission deadline is October 31, 2024. Publication of the special topic issue is planned for Spring of 2025. Articles accepted for publication after successfully completing peer-review will appear online first before the issue is compiled.

Please select the option “Call for Papers: Melody and Rhythmicity in Vocal Patterns of Prelexical Infants” when submitting your manuscript and mention this Call for Papers in your cover letter.

Folia Phoniatrica et Logopaedica supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Folia Phoniatrica et Logopaedica

Multilingual Approach in the Study, Diagnoses, and Treatment of Fluency Disorders

A significant proportion of the global population is multilingual. Nonetheless, the majority of published studies on fluency disorders have focused on monolinguals, with limited attention on multilingual speakers who stutter or clutter, raising questions about the generalizability of findings. Exploring the characteristics of multilinguals who stutter or clutter could improve our understanding of the relationship between multilingualism and fluency disorders and provide novel directions for research and practice. This special issue aims to offer insights into stuttering and cluttering within a multilingual context.

We encourage articles focused on the profile of multilingual speakers who stutter or clutter, as well as research that can improve our understanding, diagnosis, and treatment (including linguistically and culturally responsive practices, and stutter-affirming therapy) for this population. The special issue is open to papers related to theory and practice, and studies on monolinguals who stutter or clutter and typically fluent bilinguals which could help establish the relationship between multilingualism and fluency disorders. Original research, null findings, systematic reviews, and meta-analyses are welcomed. 

Please select the option “Call for Papers: Multilingual Approach in the Study, Diagnoses, and Treatment of Fluency Disorders” when submitting your manuscript and mention this Call for Papers in your cover letter.

Folia Phoniatrica et Logopaedica supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these these universities/institutions.

Cardiology

Intersection between Cancer and Cardiovascular Diseases

The Cardiology journal aims to contribute to the dissemination of original clinical research that investigates the intersection between cancer and cardiovascular diseases. Review articles that focus on understanding pathophysiological processes and best clinical practice in the field of cardio-oncology, as well as short communications that explore cardio-oncology topics, are also welcome.

We particularly wish to cover the following topics:

• Cardiovascular disease and cancer shared risk factors
• Cardiovascular toxicity of cancer therapies
• Primary and secondary cardiovascular disease prevention in patients with cancer diseases
• Safety of cardiovascular therapy in patients with cancer
• Reverse cardio-oncology

Please select the option “Call for Papers: Intersection between Cancer and Cardiovascular Diseases” when submitting your manuscript and mention this Call for Papers in your cover letter.

Cardiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cardiology

Updates on Cardiovascular Prevention

In an effort to reduce the burden of cardiovascular diseases for individual patients and at a population level, research has been focusing on identifying risk factors, risk classification, and prevention strategies based on individual patient characteristics. Cardiology’s article collection ‘Updates on Cardiovascular Prevention’ aims to bring together recent research and review articles, as well as short communications, particularly on:

• Pharmacotherapy in CVD prevention
• Lifestyle modification and its role in CVD prevention
• The role of cardiovascular rehabilitation
• Adverse pharmacological effects of non-cardiovascular drugs – impact on CV disease
• Co-morbidities in CV disease
• Risk factors and markers in CV disease

Please select the option “Call for Papers: Updates on Cardiovascular Prevention” when submitting your manuscript and mention this Call for Papers in your cover letter.

Cardiology is a Transformative Journal and supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Journal of Vascular Research

Novel Methods in Vascular and Lymphatic Physiology

The Journal of Vascular Research welcomes the submission of articles detailing novel methodologies related to the physiology and function of large and small arteries, capillaries, veins and lymphatics. The techniques used to study the function of blood vessels and lymphatics are ever expanding and advancing. Our goal is to cover advancements in imaging methodologies, fluorescent indicators, nanoparticle delivery of small molecules and genetic modifications using CRISPR-based techniques. We also welcome submissions describing methodologies or that highlight novel techniques to examine function of blood vessels and lymphatics across the macro- and microcirculation.

Please select the option “Call for Papers: Novel Methods in Vascular and Lymphatic Physiology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Journal of Vascular Research is a Transformative Journal and supports Open Access publications. Publishing in this journal will ensure authors meet a plan-S style funding mandate. In addition, corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of one of these universities/institutions.

Journal of Vascular Research

Translation from Pre-Clinical Research to Human Health and Disease: Novel Insights from Vascular Research

We welcome submission of manuscripts detailing novel insights spanning pre-clinical research to human health outcomes in vascular biology. From innovative molecular/genomic approaches to complex animal models, to advanced data analytics, computational models and biosimulation, investigators are continually deriving novel approaches to gaining new understanding of the nature of human health and disease and the impact of evolving interventions to improve outcomes.

The Journal of Vascular Research welcomes submissions describing innovative approaches, novel hypotheses, new analytic processes, and breakthrough observations providing fundamental insight into all aspects of vascular science. Submissions can include original or novel Methods Articles, Systematic Reviews, scoping reviews (please select Review Article) and expert opinions (please select Letter) [please note that narrative reviews will require prior approval from the Editor-in-Chief of the journal].

Please select the option “Call for Papers: From Pre-Clinical Vascular Research to Human Health & Disease” when submitting your manuscript and mention this Call for Papers in your cover letter.

Journal of Vascular Research is a Transformative Journal and supports Open Access publications. Publishing in this journal will ensure authors meet a plan-S style funding mandate. In addition, corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of one of these universities/institutions.

Pulse

Open Access Journal

Future Cardiovascular Medicine: AI and Telemedicine

The future of cardiovascular medicine is being significantly shaped by advancements in artificial intelligence (AI) and telemedicine, among other developments. The integration of these developments in cardiovascular medicine aims to improve patient outcomes through more personalized and timely interventions making healthcare more patient-centric. As technologies continue to evolve, they will likely become integral components of cardiovascular care.

With this collection, the Pulse journal aims to bring together Research and Review Articles on the use of AI in cardiovascular medicine to:

• accelerate diagnosis and treatment,
• enhance predictive analytics of health and disease,
• improve monitoring and provide decision support.

Also of interest are articles on the benefits of integrating telemedicine in cardiovascular care, such as:

• allowing remote monitoring,
• increasing access to care,
• improving patient engagement with disease management and treatment.

Finally, we welcome articles on the challenges of integrating these technologies in cardiovascular medicine and on the potential application of other new technologies.

Please select the option “Call for Papers: Future Cardiovascular Medicine: AI and Telemedicine” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Pulse

Open Access Journal

Vascular Structure and Function in Exercise

The Pulse journal aims to bring together in this article collection research articles, review articles, as well as brief and case reports that focus on furthering our understanding of vascular structure and function in exercise.

Topics of particular interest are:

• Vascular adaptation to exercise
• Vascular function, similarity, and disparity in physical activity versus exercise
• Analyses of the effect of exercise on arteries: arterial hemodynamic versus endothelial function
• Exercise effect on vascular function: different exercise training modalities
• Epidemiology of exercise and vascular function

Please select the option "Call for Papers: Vascular structure and function in exercise" and mention this Call for Papers in your cover letter when submitting.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Skin Pharmacology and Physiology

Advances in Skin Therapy

We are excited to announce a call for papers for an online article collection dedicated to advances in skin therapy. We welcome submissions focusing on the therapeutic aspects of skin pharmacology and physiology. Accepted articles will be published on a rolling basis and showcased on a dedicated landing page. Some possible areas of interest for the collection fit into the following themes:

• Topical Therapies
• Epidermal Barrier Function (Physiology and Pathophysiology)
• Epidermal Modulation
• Exogenous Influences on Skin Functions
• Skin Penetration of Topical Formulations
• Free Radicals and Epidermal Functions
• Climate Changes and Skin Physiology
• Diversity and Skin Physiology
• Skin Penetration: Different Routes
• Systemic Treatment Studies on Epidermal Functions
• Exposome and Epidermal Functions

This collection aims to present the most recent advancements in skin pharmacology and physiology by welcoming submissions that concentrate on scientific breakthroughs and innovations.

Please select the option “Call for Papers: Advances in Skin Therapy” when submitting your manuscript and mention this Call for Papers in your cover letter.

Skin Pharmacology and Physiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Skin Pharmacology and Physiology

Latest Developments in Research Methods

Skin Pharmacology and Physiology is currently accepting submissions for a new article collection focusing on the latest advancements in research methodologies. This collection aims to showcase innovative approaches and techniques that contribute to the study of skin conditions. Accepted articles will be published on a rolling basis and featured on a dedicated landing page. Potential submission topics include:

• Advanced Imaging Techniques
• Novel Drug Delivery Systems
• In Silico Modeling and Simulation
• High-Throughput Screening
• Bioprinting and Tissue Engineering

Submit your research to contribute to the advancement of skin pharmacology and physiology. We look forward to receiving submissions that will help shape the future of research into these areas.

Please select the option “Call for Papers: Latest Developments in Research Methods” when submitting your manuscript and mention this Call for Papers in your cover letter.

Skin Pharmacology and Physiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Hormone Research in Paediatrics

Global Challenges in Paediatric Endocrinology

Hormone Research in Paediatrics is calling for reviews, systematic reviews, brief reports, and research articles to be published in a Special Collection on challenges and advancements in Paediatric Endocrinology.

Authors are welcome to submit articles on the listed topics that will bring new insights to the research community. The articles will be rapidly peer-reviewed.

1. Puberty
2. Thyroid
3. Neonatal Endocrinology
4. Electrolyte disorders
5. Developmental Origins of Health and Disease
6. Bone and Growth
7. Paediatric and Adolescent Gynaecology
8. Sex Differentiation/DSD
9. HPA Axis
10. Obesity and Metabolism

Please select the option “Call for Papers: Global Challenges in Paediatric Endocrinology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Hormone Research in Paediatrics supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Neuroendocrinology

Epidemiology and Health Impacts of Neuroendocrine Tumors

Neuroendocrine Tumors (NETs), although relatively rare, have experienced an increase in incidence rates, attributable to advancements in diagnostic methodologies and heightened clinical awareness. These neoplasms can profoundly affect patient health and quality of life, underscoring the importance of early detection and a multidisciplinary approach to their management. Ongoing research and the development of novel therapeutic strategies are imperative for improving patient outcomes.

Neuroendocrinology is calling for original research and review articles for its upcoming Special Topic Issue “Epidemiology and Health Impacts of Neuroendocrine Tumors”. This Special Topic Issue, curated by Editors Prof. Dr. R. Srirajaskanthan and Prof. Dr. J. Ramage, aims to propel forward the research, diagnosis, and treatment of neuroendocrine tumors.

Please select the option “Call for Papers: Epidemiology and Health Impacts of Neuroendocrine Tumors” when submitting your manuscript and mention this Call for Papers in your cover letter.

Neuroendocrinology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Complementary Medicine Research

Complementary Medicine in Oncology

Complementary therapies can play a valuable role in oncology care by addressing the physical, emotional, and psychological needs of patients. When integrated with conventional treatments under the guidance of qualified healthcare providers, these approaches can enhance the overall treatment experience and improve the quality of life for cancer patients.

Complementary Medicine Research calls for papers that discuss the role of complementary medicine approaches in oncology.

Please select the option “Call for Papers: Complimentary Medicine in Oncology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Complementary Medicine Research supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digital Biomarkers

Open Access Journal

Digital Biomarkers for Motion Detection

We are excited to announce a call for papers for our upcoming Article Collection on “Digital Biomarkers for Motion Detection” in our journal Digital Biomarkers. We encourage researchers, clinicians, and technologists to contribute original research articles, reviews, and case studies exploring the field's cutting-edge developments.

Topics of interest include, but are not limited to:

• Disease-Agnostic Digital Biomarkers: Universal digital biomarkers for monitoring motion.
• Device-Agnostic Digital Biomarkers: Advancements in identification and validation.
• Real-World Data: Leveraging everyday data on motion for health insights.
• Neuromuscular Diseases (e.g., Multiple Sclerosis or Duchenne Muscular Dystrophy): Innovations in diagnosis and monitoring, tracking disease progression, and enhancing patient care.
• Exercise and Movement: Digital monitoring for optimizing physical activity.
• Wearables, Sensors, and Ingestibles: The latest in wearable health technology and internal health monitoring.
• Accelerometry: Precision motion detection and analysis.
• Cardiotocography (CTG): Digital approaches in fetal monitoring.

Submissions should present novel findings, contribute significantly to the field, and adhere to the highest scientific and ethical standards. All manuscripts will undergo a rigorous peer-review process to ensure quality and relevance.

Please select the option “Call for Papers: Digital Biomarkers for Motion Detection” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digital Biomarkers

Open Access Journal

The State of Digital Biomarkers and Mental Health

This article collection of the journal Digital Biomarkers, focused on mental health technologies, provides a venue for publishing advances in Digital Biomarkers and phenotypes for mental health. Papers that describe the development, validation, and deployment of theory-driven technologies in digital mental healthcare are encouraged.

Digital biomarkers and phenotypes are emerging as powerful tools for quantifying human health. These approaches, which leverage advances in wearable sensors, mobile technology, and data analytics, enable the discovery of new markers of disease that are well suited for capture and monitoring at scale. Digital biomarkers and phenotypes may be most impactful for mental health conditions, where there is a relative paucity of established objective biomarkers, and the ability to capture measures of disease outside of traditional research or clinical contexts is truly enabling. Conditions where these biomarkers may have the most impact have been identified, with initial focus directed to conditions where symptoms cannot be reported reliably, for episodic conditions, and for conditions with rapidly changing and/or context-dependent symptoms.

Past efforts in digital mental healthcare have focused on delivering traditional in-person assessment and interventions accessibly such as web- or phone-based talk therapy and/or telehealth video-consulting. While making great gains in service accessibility, these efforts inherently carry similar limitations to in-person interventions, such as poor user engagement and requirement for reliable reporting and trained clinicians. Digital biomarkers and phenotypes for mental health conditions could diminish these limitations, offering new tools to detect, monitor, and give feedback on mental health symptoms to users and their providers alike. Importantly, there is a distinct lack of rigorous validation of digital mental health tools. Thus, there is a critical and unmet need for validated digital biomarkers and phenotypes that enable objective and remote mental health assessments across the lifespan. Researchers from groups throughout the world are working to address this critical unmet need.

Please select the option “Call for Papers: The State of Digital Biomarkers and Mental Health” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestion

Artificial Intelligence in Gastroenterology

The integration of Artificial Intelligence (AI) into the realm of gastroenterology has manifested notably in clinical practice, primarily exemplified by the incorporation of polyp detection systems in colonoscopy. While this constitutes a significant stride, it is imperative to acknowledge that the transformative influence of AI in gastroenterological disciplines extends beyond polyp detection. Ongoing efforts are focused on the creation and refinement of innovative AI tools intended to support healthcare professionals in both research and clinical applications. This article collection, entitled “Artificial Intelligence in Gastroenterology”, seeks to compose a comprehensive overview of the latest advances in this burgeoning field. The primary objective is to delineate and accentuate the endeavors of research groups that are propelling the discipline forward through pioneering AI applications. This collection welcomes Research Articles and Systematic Reviews, and aims to encapsulate the diverse array of AI tools emerging in gastroenterology, showcasing their potential to redefine conventional practices and contribute to the evolution of the discipline. Researchers are invited to contribute their valuable insights to this article collection and, thereby, actively participate in shaping the trajectory of the influence of AI within the field of gastroenterology.

Please select the option “Call for Papers: Artificial Intelligence in Gastroenterology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestion supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestion

Current Management of Duodenal Neoplasia

Duodenal neoplasms were once considered to be very rare and, due to this rarity, their biological behavior and precise diagnostic methods have long been poorly understood compared to other tumors of the gastrointestinal tract. Additionally, endoscopic treatment for duodenal neoplasia has been known to be highly dangerous because of the duodenum's anatomical feature of being fixed to the retroperitoneum and its exposure to bile and pancreatic fluid. However, recent improvements in endoscopic equipment and increased awareness among endoscopists have led to a better understanding of the biological behavior and endoscopic diagnosis of duodenal neoplasia. Moreover, improved treatment outcomes have been achieved through the development of devices, refined treatment techniques, and the establishment of perioperative management.

This article collection, entitled “Current Management of Duodenal Neoplasia”, aims to provide a comprehensive overview of the latest advances in this rapidly growing field. The primary objective is to identify and highlight the efforts of research groups that are advancing the field of diagnosis and endoscopic management for duodenal neoplasia. Researchers are welcome to contribute their valuable insights in the form of research articles and systematic reviews.

Please select the option “Call for Papers: Duodenal neoplasia” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestion supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestion

Endoscopic Diagnosis and Treatment of Esophagogastric Junction Disorders: Gastroesophageal Reflux Disease (GERD) and Achalasia

Gastroesophageal reflux disease (GERD) and achalasia are characterized by dysfunction of the esophagogastric junction. While endoscopy is valuable for excluding organic diseases and assessing reflux esophagitis severity in GERD, its role in non-erosive reflux disease pathophysiology evaluation remains uncertain. Various endoscopic treatments for GERD have been reported, yet standardization is lacking. Regarding achalasia, endoscopic evaluation alone may not suffice for diagnosing it in most cases. Per-oral endoscopic myotomy (POEM) has emerged as an effective primary treatment for achalasia; however, optimization debates persist.

This article collection aims to present current evidence on endoscopic approaches for managing GERD and achalasia. Additionally, it proposes future directions for the role of endoscopy in both the diagnosis and treatment of these conditions.

The range of contributed articles is envisaged to address the following topics:

• The pathophysiology of GERD and achalasia
• The role of endoscopy in diagnosing GERD (including NERD) and achalasia
• Indications for endoscopic treatments for GERD and achalasia
• Clinical outcomes of endoscopic treatments for GERD and achalasia
• Cost-effectiveness of endoscopic treatments for GERD and achalasia (if applicable)

Authors are welcome to submit research, review, and systematic review articles.

Please select the option “Call for Papers: GERD and Achalasia” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestion Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestion

Microbiome

Technological advances have expanded our knowledge about the microbiome. The intestinal microbiome, in particular, is now considered a “hidden organ” that plays a crucial role in human health. Understanding the healthy and aberrant interactions between the microbiome and the host can help establish the pathogenesis of diseases and develop preventive and therapeutic interventions. In this collaborative project between Digestion and Digestive Diseases, Research, Review, and Systematic Review articles on the microbiome and digestive diseases or the gut microbiome and systemic diseases are welcome. We envisage that this project will provide updates with the latest in the field for a broad audience.

Please select the option “Call for Papers: Microbiome” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestion supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestive Diseases

Microbiome

Technological advances have expanded our knowledge about the microbiome. The intestinal microbiome, in particular, is now considered a “hidden organ” that plays a crucial role in human health. Understanding the healthy and aberrant interactions between the microbiome and the host can help establish the pathogenesis of diseases and develop preventive and therapeutic interventions. In this collaborative project between Digestive Diseases and Digestion, Research, Review, and Systematic Review articles on the microbiome and digestive diseases or the gut microbiome and systemic diseases are welcome. We envisage that this project will provide updates with the latest in the field for a broad audience.

Please select the option “Call for Papers: Microbiome” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestive Diseases supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestive Surgery

Article Collections of Digestive Surgery

We welcome the submission of Research, Review, Brief Report, and Methods articles to the following article collections:

• Treatment of Complications in Digestive Surgery
• Upper Gastrointestinal Tract (GI) Cancers

Please mention the article collection title in your Cover Letter when submitting your article. We look forward to receiving your manuscript.

Digestive Surgery

Colorectal Cancer

Digestive Surgery is launching the article collection titled ‘Colorectal Cancer’. In 2024, more than 520,000 individuals are anticipated to be diagnosed with colorectal cancer (CRC) in Europe, and an estimated 250,000 are expected to succumb to the disease, making CRC a social healthcare issue. Moreover, the marked increase in early-onset CRC and the fast-rising burden in low- and mid-socio-demographic index countries, observed in recent years, have generated substantial disparities in the epidemiology, screening process, and treatment, evoking particular concern. A concerted effort in the dissemination of knowledge on this condition is, therefore, imperative to address contemporary challenges in the management of CRC. Notably, surgeons continue to be at the forefront of the diagnosis and treatment of CRC, even at advanced stages, and the surgical community will lead pivotal therapeutic innovations in the future.

The Editors-in-Chief of Digestive Surgery believe that an article collection specifically dedicated to CRC is now crucial to accelerate the comprehension of the disease, its biological peculiarities, as well as current and future surgical approaches integrated with the most recent advances in molecular treatments. Researchers are welcome to contribute Research Articles, Systematic Reviews, and Review Articles to this collection, focusing on current and forthcoming opportunities for the diagnosis, screening processes, and multimodal treatment of CRC. Ensuring a thorough and rapid peer-review process by a highly selective, international expert panel, we are eager to provide the community with the latest insights on CRC from a surgical perspective, with the aim to inform clinical practice and future research.

Please select the option “Call for Papers: Colorectal Cancer” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestive Surgery supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestive Surgery

Esophagogastric Cancers

The number of patients affected by esophagogastric cancers has been increasing, raising challenges in treatment choice for this patient group. Advances in neoadjuvant treatment modalities and improvement of operative treatment modalities have improved outcomes in the last decades. Moreover, improved postoperative management has resulted in a decrease in the postoperative complication rate and better long-term outcomes after extensive surgery. To address this topic, Digestive Surgery is creating a new article collection on esophagogastric cancers to capture the latest on the diagnosis, neoadjuvant treatment, and operative approach to these malignancies. Authors are welcome to contribute Research, Review, and Systematic Review articles. The editors look forward to receiving the authors’ articles for the improvement of the management of patients.

Please select the option “Call for Papers: Esophagogastric Cancers” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestive Surgery supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestive Surgery

Hepato-pancreato-biliary (HPB) Cancers

A constant increase in the number of patients has been affected by Hepato-Pancreato-Biliary (HPB) Cancers, posing tremendous management challenges for clinicians. Fortunately, advances in the screening process, diagnostic modalities, and opportunities for cure have been unprecedented in recent years. Novel techniques, including the implementation of artificial intelligence and biology-driven personalised medicine, have expanded the indications for surgery and revolutionised the traditional management of HPB diseases. Striving to offer continuous, top-level education and guidance for the practising surgeon, Digestive Surgery is creating a new article collection on HPB cancers to provide readers with state-of-the-art perspectives concerning the diagnosis and treatment of such malignancies. Authors are welcome to contribute Research, Methods, Review, and Systematic Review articles. The editors are eager to receive the article contributions for the improvement of the management of patients.

Please select the option “Call for Papers: HPB Cancers” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestive Surgery supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Digestive Surgery

Rare Cancers of the Gastrointestinal Tract and Peritoneum

Digestive Surgery is calling for submissions to the article collection "Rare Cancers of the Gastrointestinal Tract and Peritoneum”.

Rare cancers of the gastrointestinal tract and peritoneum, such as gastrointestinal stromal tumors (GIST), mesothelioma, and pseudomyxoma peritonei, present distinct diagnostic and therapeutic challenges. Additionally, the landscape of treatment for peritoneal carcinomatosis is constantly evolving, with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) and other modalities offering promising improvements in patient outcomes.

Our goal is to gather high-quality original research, reviews, and systematic reviews that elucidate the pathophysiology, diagnosis, and innovative treatment approaches for these rare cancers. We aim to foster collaboration and knowledge-sharing among researchers, clinicians, and other healthcare professionals.

We welcome articles that cover a wide range of topics, including molecular biology, clinical trials, patient management strategies, and emerging therapies. Contributions that provide new insights into epidemiology, early detection, and personalized medicine are highly encouraged.

Please select the option “Call for Papers: Rare Gastrointestinal and Peritoneal Cancers” when submitting your manuscript and mention this Call for Papers in your cover letter.

Digestive Surgery supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Inflammatory Intestinal Diseases

Open Access Journal

Article Collections of Inflammatory Intestinal Diseases

We welcome the submission of Research, Review, Systematic Review, Brief Report, and Methods articles to the following article collections:

• Disease Monitoring, Including Biomarkers and Advanced Imaging Modalities in Inflammatory Bowel Disease (IBD)
• Short- and Long-term Real-World Outcomes of Advanced Therapies for Inflammatory Bowel Disease (IBD)
• Eosinophilic Oesophagitis
• Coeliac Disease and Non-Coeliac Gluten Sensitivity

Please mention the article collection title in your Cover Letter when submitting your article. We look forward to receiving your manuscript.

Visceral Medicine

Pregnant Patients with Gastrointestinal Problems

Pregnancy is a very exciting event in the life of a woman, and pregnant women as well as their environment feel anxious about what they should (or should not) do for their own and their baby's health. While pregnancy itself causes changes in all body systems in response to the growing fetus that may cause distress, gastrointestinal problems, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease or proctological problems are common in pregnant patients due to multiple factors. And some gastrointestinal infections, e.g., Helicobacter pylori infection, might acerbate pregnancy-related complications, such as severe vomiting in pregnancy, hyperemesis gravidarum, functional dyspepsia, and spontaneous preterm birth. Although most gastrointestinal cancers are diagnosed beyond the age of fertility and predominantly in men, the increasing incidence rates of gastrointestinal malignancies in patients below the age of fifty suggest a growing risk in women of child-bearing age. If health disorders, such as abdominal pain, diarrhea, pelvic pain, or fever occur, treating physicians are challenged to choose the right treatment that considers the wellbeing of mother and child.

For this article collection, we welcome original research articles, brief reports, case reports, and review articles that focus on the treatment options for gastrointestinal diseases in pregnant patients.

Please select the option “Call for Papers: Pregnant Patients with Gastrointestinal Problems” when submitting your manuscript and mention this Call for Papers in your cover letter.

Visceral Medicine supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Biomedicine Hub

Open Access Journal

Advances in Palliative Care

As an interdisciplinary “hub”, the Biomedicine Hub journal aims to highlight recent advances in palliative care and the importance of an interdisciplinary approach to improving the quality of life of patients with life-threatening diseases. For this article collection the journal will consider research articles, review articles, evidence-based protocols, as well as case reports and brief reports.

Topics of particular interest are:

• model palliative care programs
• medical advances in pain and symptom management
• ways of improving the understanding of the illness and its progression
• how to help patients to cope with feelings and changes related to the illness
• ways of assisting in understanding treatment options, making treatment decisions, and coordinating care

Please select the option “Call for Papers: Advances in Palliative Care” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Biomedicine Hub

Open Access Journal

Embracing Negative Results in General Medicine

The journal Biomedicine Hub would like to highlight the critical role of negative results in advancing biomedical research by welcoming Research and Review Articles, Registered Reports, Systematic Reviews, and Letters that discuss null findings, inconclusive, or failed replications of previously published work. We aim to showcase studies that challenge the status quo, question underlying assumptions, and provide valuable insights despite not achieving the anticipated outcomes.

TWe welcome submissions of manuscripts covering one or several of the following aspects:

• well-conducted, scientifically-valid studies with negative, null, or non-significant findings;
• role of negative results for hypothesis development and testing;
• methodological challenges and lessons learned from studies yielding negative results;
• discussion of bias linked to negative findings and ways to overcome it.

Please select the option “Call for Papers: Embracing Negative Results in General Medicine” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cytogenetic and Genome Research

Emerging Trends in Cytogenetic and Genome Research

Cytogenetic and Genome Research publishes research in clinical, molecular, and comparative cytogenetics and genomics. In order to highlight the important work being done in this field, the journal is launching an article collection that brings together the latest research. Whilst not exclusive, we welcome contributions that delve into a variety of domains, that may emphasize:

• Genetic foundations for advancements in diagnosis, treatment, and prevention.
• Human Genetics and the bases of human diseases.
• Plant Cytogenetics and Genomics and examinations of the structure and function of plant chromosomes.
• Animal Genomics and variations within breeds to further an understanding of animal genetics.
• Epigenetics and studies of epigenetic mechanisms.
• Chromosome structure, function, and evolution with attention paid to sex chromosomes, centromeres, telomeres, and other repetitive DNA families.

Authors are encouraged to submit manuscripts that contribute to the evolving landscape of genetic and genomic research, providing valuable insights into these dynamic fields.

Please select the option “Call for Papers: Emerging Trends in Cytogenetic and Genome Research” when submitting your manuscript and mention this Call for Papers in your cover letter.

Cytogenetic and Genome Research is a Transformative Journal and supports Open Access publications. Publishing in this journal will ensure authors meet a plan-S style funding mandate. In addition, corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of one of these universities/institutions.

Human Heredity

Open Access Journal

Highlights in Human Heredity

Human Heredity publishes cutting-edge methodological and applied research on the genetics of human populations, association and linkage analysis, genetic mechanisms of disease, and new methods for statistical genetics.

This year, in 2024, the journal is launching a new article collection that brings together the field’s latest research. Articles will be published on a rolling basis and feature on a dedicated landing page for the collection.

We welcome contributions on the following topics:

• Ancient DNA
• Structural Variation
• Multi-Omics
• Gene-Networks
• Statistical Genetics Software
• Methods for the Analysis of Summary Statistics
• Applicability and Limitations of Polygenic Scores

We welcome researchers to submit their research and contribute to a collection that will advance our understanding of human genetics.

Please select the option “Call for Papers: Highlights in Human Heredity” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Molecular Syndromology

Precision Medicine

Molecular Syndromology invites submissions for an article collection dedicated to precision medicine. Building upon the journal’s established strength int this area, we are particularly interested in research papers and reviews that explore innovative treatment opportunities. Areas of focus might include:

• Studies of precision medicine approaches in the context of genetic disorders.
• Molecular genetic techniques.
• Studies on synaptic protein expression and its implications for disease treatment.
• Investigations into specific gene mutations (e.g., NEXMIF, GRIN2A, GRIN2B, GRIN2D)
• Novel therapeutic strategies and drug evaluations for genetic disorders, including epileptic encephalopathies.
• Analyses of treatment variability and response in patients with similar genetic profiles.

Please select the option “Call for Papers: Precision Medicine” when submitting your manuscript and mention this Call for Papers in your cover letter.

Molecular Syndromology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Molecular Syndromology

Genetic and Clinical Characterization of Genes Associated with Novel Genetic Disorders

We invite original research on the identification and characterization of novel genetic disorders using next-generation sequencing and other advanced technologies. The topics of interest include neurodevelopmental disorders, genetic skeletal disorders, rare skin disorders, infertility, and complex syndromes, as well as high-throughput technologies, new therapeutic approaches, gene editing and genomics, and GWAS. Join us in advancing our understanding of the genetic basis of human health and disease.

Please select the option “Call for Papers: Genetic and clinical characterization of genes associated with novel genetic disorders” when submitting your manuscript and mention this Call for Papers in your cover letter.

Molecular Syndromology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Gerontology

Infection and Inflammation in Alzheimer’s Disease

Alzheimer’s disease (AD) is a complex neurodegenerative disorder, with increasing evidence highlighting the critical roles of infection and inflammation in its development and progression. We welcome submissions that explore the intricate connections between infections, chronic inflammation, and Alzheimer’s pathology.

Recent research suggests that microbial and viral pathogens may contribute to the accumulation of amyloid-beta, a protein central to AD that also serves as a potential antimicrobial agent. This dual role implies that amyloid-beta accumulation may initially act as a defence mechanism against brain infections but, when dysregulated, contribute to AD.

Neuroinflammation, driven by the brain’s immune response, is also recognized as a significant factor exacerbating neuronal damage and cognitive decline in AD. Chronic inflammation —not only localized within the brain but also peripheral inflammation— appears to play a pivotal role in disease progression, creating a vicious cycle of ongoing neurodegeneration.

We welcome original research, reviews, and case studies that investigate the interplay between infection and inflammation in AD. Topics of interest include, but are not limited to, the impact of specific pathogens, immune responses in AD, and novel therapeutic approaches targeting inflammation and infection in the context of AD.

Please select the option “Call for Papers: Infection and Inflammation in Alzheimer’s Disease” when submitting your manuscript and mention this Call for Papers in your cover letter.

Gerontology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Gerontology

Regenerative Medicine for Aging

The journal Gerontology solicits papers in the field of regenerative medicine.

The human life span has almost doubled in the past 70 years; however, the number of disease-free years has not kept pace. Chronic, age-related diseases often characterize the last decade of life, and affect its quality. Extending longevity in good health is essential to increase the quality of life of aged people and diminish the cost burden to society.

The Regenerative section of Gerontology welcomes research papers focusing on new solutions for increasing health span via regenerative approaches and anti-senescent investigation. Topics covered include but are not limited to:

• Nutrition therapies
• Medical weight loss therapies
• Hormone replacement therapies
• Stem cell therapies
• Tissue engineering
• Immunomodulation therapy

Please select the option “Call for Papers: Regenerative Medicine for Aging” when submitting your manuscript and mention this Call for Papers in your cover letter.

Gerontology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Transfusion Medicine and Hemotherapy

Open Access Journal

Importance of HLA for Transplantation

Solid organ transplantation is a fast-evolving field in medicine with a strong interdisciplinary character. HLA diagnostics and histocompatibility are important cornerstones for successful organ transplantation and are thus anchored in guidelines by the German Medical Association (Bundesärztekammer) and Eurotransplant. Ever since the first introduction of histocompatibility testing in organ transplantation in the late 1960s, HLA diagnostics have evolved substantially. Nowadays, there is a broad and more sophisticated portfolio of analyses (e.g. HLA epitope analysis) available, which allow a more differentiated risk assessment prior to and following transplantation. We are calling for review and original papers on the importance of HLA in the field of transplantation for an article collection in Transfusion Medicine and Hemotherapy entitled “Importance of HLA for Transplantation”.

Potential authors are invited to submit manuscripts on this topic that will be rapidly peer-reviewed.

Please select the option “Call for Papers: Importance of HLA for Transplantation” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

International Archives of Allergy and Immunology

Climate Change & Immunology

We are excited to announce a Call for Papers for our "Climate Change, Allergy and Immunology" IAA Article Collection. This collection focuses on the complex and growing interplay between climate change and the increasing prevalence of allergic diseases. We aim to feature cutting-edge research, reviews, and meta-analyses that explore how environmental changes, such as increasing temperatures, shifts in weather and pollen patterns, air quality, and toxic exposures, impact allergy development and disease severity. Authors are encouraged to submit articles that contribute to this critical conversation, and we look forward to your innovative contributions.

If you are interested in contributing, please feel free to reach out, as we are eager to collaborate with researchers passionate about this field.

Please select the option “Call for Papers: Climate Change & Immnunology” when submitting your manuscript and mention this Call for Papers in your cover letter.

International Archives of Allergy and Immunology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these these universities/institutions.

Journal of Innate Immunity

Open Access Journal

Biofilms

This article collection of the Journal of Innate Immunity is dedicated to unraveling the multifaceted interactions between biofilms and innate immunity. Our primary aim is to showcase innovative research investigating the impact of biofilm formation on host immune responses and the intricate strategies employed by pathogens within these structured microbial communities. We welcome submissions exploring the immunological challenges posed by biofilms in various contexts, such as chronic infections, medical devices, and human or animal niches. This collection seeks to bridge the gap between microbiology and immunology, fostering a comprehensive understanding of how biofilms influence innate immune mechanisms. Contributions elucidating novel therapeutic approaches targeting biofilm-associated immune evasion are particularly encouraged. Through this curated collection, we strive to advance knowledge in the field, ultimately informing strategies for the development of more effective interventions against biofilm-related diseases.

Please select the option “Call for Papers: Biofilms” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Journal of Innate Immunity

Open Access Journal

Immunometabolism

The impact of immunometabolites in the pathogenesis of infection is increasingly appreciated. In this focused issue of the Journal of Innate Immunity we are showcasing articles that illustrate the varied roles of immunometabolites in viral and bacterial infection. We hope to include both primary research and reviews that detail how both host and pathogen metabolites affect immune responses. Studies on the immunometabolic responses to viral infections, especially SARS CoV2 and influenza, are encouraged. Bacterial infection due to intracellular pathogens such as M. tuberculosis and Salmonellae as well as predominantly extracellular pathogens including S. aureus and S. pneumoniae will be included.

Please select the option “Call for Papers: Immunometabolism” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Neuroimmunomodulation

Open Access Journal

COVID-19, Hormones and Brain

In the pathogenesis and the progression of COVID-19, Involvement of gender (sex hormones), secosteroids (Vitamin D), glucocorticoids (used for therapy, but also since altered by stress of the disease), together with other nonsteroidal hormones, and neuroendocrine pathways are recognized as critical pathophysiological factors.

A pioneer issue of Neuroimmunomodulation is now dedicated to “COVID-19, Hormones and Brain”. It will show an article collection on this topic from basic and clinical science, that helps to understand this fundamental aspect.

Potential authors are invited to submit articles that will be rapidly peer reviewed. The article should demonstrate crosstalk between hormones and viral infection in the context of COVID-19.

Please mention the Call for Paper in your Cover Letter when submitting.

Neuroimmunomodulation

Open Access Journal

Microbiota and Gut-Brain Connection in Neuroinflammation

Increasing lines of evidence have shown the gut-brain connection in both physiological and pathophysiological conditions. The connection is not simply through neuronal pathways, such as the vagus nerve. The community composition of the gut microbiome and the metabolites being produced by microorganisms in the gut can also affect the brain including cognition, mental/psychological functions, and neuroinflammation, which can further modulate progression of neuropsychiatric and neurodegenerative diseases.

This article collection aims to collect articles describing the lates developments on the effect of “Microbiota and Gut-Brain Connection in Neuroinflammation”. We welcome original research articles (both experimental and clinical), brief reports, methods and review articles focusing on, but not strictly limited to, the following topics:

1. experimental studies of how modifying microbiota in the gut affects neuroinflammation
2. involvement of different immune cells such as macrophages, lymphocytes or innate lymphoid cells affected by microbiota to modulate their infiltration in the brain
3. how neuroinflammation affects gut and microbiota
4. how systemic inflammation modulates microbiota leading to modulation of immune cells in neuroinflammation
5. how disturbances of endocrine systems affect microbiota in the gut leading to modulation of neuroinflammation.

Please select the option “Call for Papers: Microbiota and Gut-Brain Connection in Neuroinflammation” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

American Journal of Nephrology

New Insights in Onconephrology

American Journal of Nephrology aims to dedicate an article collection to recent advancements in onconephrolgy. Authors are welcome to submit research articles and reviews that present novel concepts and insights to the research community as well as highlight the controversies that need future research.

Topics of particular interest include but are not limited to:

• Renal cell carcinoma
• CKD, AKI and glomerular diseases in patients with cancer
• Kidney functions in patients with cancer
• Kidney disease in stem cell transplantation
• Clinical surveillance and management strategies for drug-induced and cancer immunotherapies nephrotoxicity (ICI, CAR-T, urinary T-cells and serum biomarkers)
• Electrolyte disorders in patients with cancer
• Therapeutics and diagnostics in onconephrology
• Epidemiology of risk, disease presentation, and treatment effects in onconephrology

Submitted articles will be rapidly peer-reviewed and published online within a few days from acceptance.

Please select the option “New Insights in Onconephrology” when submitting your manuscript and mention this Call for Papers in your cover letter.

American Journal of Nephrology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Blood Purification

Green Renal Replacement Therapy: Caring for the Environment

Human-induced climate change is considered the greatest health threat of the 21st century. Healthcare contributes approximately 4.5% of global annual greenhouse gas production. Within hospitals, renal replacement therapy (RRT) has been estimated as one of the major contributors through greenhouse gas emission, depletion of natural resources and generation of waste. Strategies are needed to mitigate this impact and improve the long-term environmental sustainability of acute and chronic RRT.

Blood Purification aims to dedicate an article collection to “Green Renal Replacement Therapy”. Authors are welcome to submit research articles and reviews that present novel concepts and insights to the research community as well as knowledge gaps that need future research.

Topics of particular interest include but are not limited to:

• Analysis of the carbon footprint associated with different RRT modalities
• Strategies for resource conservation in the provision of dialysis treatment
• Introduction of environmentally friendly RRT practices
• Development and evaluation of educational programs on the environmental impact of RRT
• Proposals for integrating renewable energy sources for RRT
• Strategies to minimize waste generation during RRT, including the re-use and re-cycling of materials
• Exploration of patient preferences and attitudes toward environmentally sustainable RRT options
• Comparative studies on the environmental impact of RRT in different regions and healthcare systems
• Collaborative initiatives to reduce the global environmental footprint of RRT

By addressing these topics, authors can contribute valuable insights to the field of green RRT and provide actionable insights for making RRT more environmentally sustainable.

Please select the option “Call for Papers: Green Renal Replacement Therapy: Caring for the Environment” when submitting your manuscript and mention this Call for Papers in your cover letter.

Blood Purification supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cardiorenal Medicine

Open Access Journal

Cardiorenal Medicine: Exploring New Frontiers in Metabolism and Obesity

The links between cardiorenal medicine, metabolic disorders and obesity have become a major focus of modern medical research. Cardiorenal diseases, metabolic disorders and obesity form a complex network of mutually reinforcing conditions. In recent years, the links between these diseases and the mechanisms that influence them have received increasing attention as people's living habits shift and the incidence of obesity climbs. Our understanding of these mechanisms continues to improve, while new therapeutic strategies are being explored.

The Cardiorenal Medicine journal calls for papers on the interactions between heart, kidneys, metabolism and obesity in different settings, with a particular emphasis on new concepts and controversies that require future research. For this article collection on “Cardiorenal Medicine: Exploring New Frontiers in Metabolism and Obesity”, the journal will consider original research articles, brief reports, and review articles focusing on, but not limited to, the following topics:

• The association between obesity and cardiorenal dysfunction
• Molecular mechanisms of obesity-related cardiorenal dysmetabolism
• Long-term effects of metabolic syndrome on cardiorenal function
• Metabolic regulation strategies in the cardiorenal syndrome
• Metabolic adaptation and energy balance in cardiorenal disease
• Obesity and microvascular complications in cardiorenal disease
• Dyslipidemia in obesity and cardiorenal disease

Please select the option “Call for Papers: Cardiorenal Medicine: Exploring New Frontiers in Metabolism and Obesity” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cardiorenal Medicine

Open Access Journal

Emerging Cardiorenal Concepts and Controversies

The pathophysiologic pathways linking cardiovascular disease and kidney dysfunction are complex and have been the focus of intense investigations over the past several years. There have been significant advances in our understanding of these mechanisms and several therapeutic agents have also been introduced.

The goal of this Call for Papers is to bring together articles related to interactions between the heart and the kidney in a variety of settings with special emphasis on the novel concepts as well as the controversies that need future research. For this article collection "Emerging Cardiorenal Concepts and Controversies", the journal will consider original research articles, brief reports, and review articles focusing on, but not limited to, the following topics:

• Hypertension in heart failure
• Biomarkers in heart failure and cardiorenal syndrome
• Kidney-heart transplant in cardiorenal syndrome
• Kidney in advanced heart failure
• Diuretic resistance and decongestive strategies in heart failure
• Precision medicine and cardiorenal syndrome

Please select the option “Call for Papers: Emerging Cardiorenal Concepts and Controversies” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cardiorenal Medicine

Open Access Journal

Fluid Overload in Cardiorenal Medicine: From “Bench to Bedside”

The phenomenon of volume overload has received considerable attention in cardiorenal research in recent years. In the current Special Collection of Cardiorenal Medicine, we welcome researchers to submit their original work that contributes to a deeper understanding of this complex process. We welcome manuscripts that address various aspects, ranging from the underlying pathophysiology to clinical challenges, including but not limited to diagnosis, risk assessment, novel biomarkers, monitoring, and management. Through these contributions, we aim to enrich the existing body of knowledge on volume overload and its multifaceted implications in cardiorenal syndrome.

Please select the option “Call for Papers: Fluid overload in Cardiorenal Medicine: From “bench to bedside” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Glomerular Diseases

Open Access Journal

Advances in Diabetic Kidney Diseases

Glomerular Diseases is a first-in-class open access peer-reviewed journal focusing exclusively on the glomerulus with the overarching purpose to disseminate cutting-edge clinical knowledge and expertise in all areas of basic and clinical science relevant to the glomerulus to accomplish precision medicine for patients with glomerular diseases.

In recognition of the robust novel treatment options for diabetic kidney diseases, Glomerular Diseases plans a Special Collection on “Advances in Diabetic Kidney Disease (DKD)”. Authors are welcome to submit original research, case series, state-of-the-art reviews, case reports of unique value, and opinion pieces reporting advances in DKD in the areas of:

• Novel pathogenetic insights
• Future treatments
• DKD prognostic indices
• Relationship between DKD and cardiovascular disease
• Cellular mechanisms of SGLT2i in attenuation of DKD
• Gut microbiota in DKD
• Animal models
• Serum and urine biomarkers
• MicroRNAs in DKD pathogenesis and treatment
• DKD "Omics": Proteomics, Pepdidomics, Metabolomics, Genomics

Glomerular Diseases releases accepted manuscripts in a continuous fashion upon acceptance after peer-review.

Please select the option “Call for Papers: Advances in Diabetic Kidney Diseases” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Glomerular Diseases

Open Access Journal

Advances in Lupus Nephritis

Glomerular Diseases is a first-in-class open-access peer-reviewed journal focusing exclusively on the glomerulus. Its overarching purpose is to disseminate cutting-edge clinical knowledge and expertise in all areas of basic and clinical science relevant to the glomerulus to accomplish precision medicine for patients with glomerular diseases.

In recognition of ongoing biomarker discoveries and new therapeutic options for lupus nephritis, Glomerular Diseases plans an Article Collection on “Advances in Lupus Nephritis”. Authors are welcome to submit original research, case series, state-of-the-art reviews, and case reports of unique value reporting advances in lupus nephritis in the areas of:

• Novel pathogenetic insights
• Serum, urine and histologic biomarkers
• Histopathologic classifications and indices
• Lupus nephritis risk scores
• Current and future treatments
• Gut microbiota in lupus nephritis
• Animal models
• Lupus nephritis "Omics": Proteomics, Transcriptomics, Peptidomics, Metabolomics, Genomics

Please select the option “Call for Papers: Advances in Lupus Nephritis” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Kidney and Blood Pressure Research

Open Access Journal

Kidney Stone Disease

Kidney stone disease is a multifactorial disease that has a high prevalence and recurrence rate. Both genetic and environmental factors contribute to pathophysiology. Recurrent stone disease is associated with an increased risk progressing to chronic kidney disease and also with adverse cardiovascular outcomes. Recent advances in genetics, in our understanding of metabolic and nutritional factors, and important clinical trials have produced new insights into the pathogenesis, prevention and treatment of stone disease.

This call for papers aims to collect research articles and reviews describing advances in the field of kidney stone disease and its relationship to other conditions such as cardiovascular or metabolic disorders. Topics of particular interest are:

• Epidemiology of kidney stone disease and its associated socioeconomic costs
• Genetics of kidney stone disease
• Cellular mechanisms of crystal formation and intrarenal processes
• Diagnosis of stone disease and underlying biochemical traits
• Nutrition and kidney stone disease
• Microbiome and kidney stone disease
• Prevention of stone disease
• Therapies of stone disease

Please select the option “Call for Papers: Kidney Stone Disease” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Kidney and Blood Pressure Research

Open Access Journal

Kidney Function and Omics Science

The advent of the omics sciences is changing our knowledge in the medical field. Omics are acquiring great importance in defining the pathogenesis, helping the diagnosis and devising new therapies for many diseases. The possibility to conduct omics investigations at the single cell level and, with the advent of space omics, to reconstruct the entire function of an organ are truly revolutionizing the medical field. The kidney, with its complex anatomical architecture and its profound cellular differentiation, can greatly benefit from these new technologies.

This call for papers aims to collect research articles and reviews describing how omics technologies are changing our knowledge of renal function and the repercussions they have in the field of physiopathology, diagnostics, and therapy of renal diseases. Topics of particular interest are:

• Application of omics approaches in rare renal diseases
• Characterization of urinary extracellular vesicles
• Characterization of urine-derived renal progenitors
• Single cell transcriptomics of normal and diseased renal cells
• Spatial genomics and proteomics of normal and diseased renal cells

Please select the option “Call for Papers: Kidney Function and Omics Science” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Kidney and Blood Pressure Research

Open Access Journal

Novel Drugs in the Nephrology Arena

Clinical Nephrology is living a paradigm shift, from a focus on solution for kidney failure towards preventing and slowing its progression. This has been possible thanks to the development of new molecules with proved efficacy on kidney protection and, for the first time, even on the reduction of cardiovascular risk. Several molecules are already on the market, others are in the pipeline. Major innovations have occurred for the management of kidney failure, however new options are available also for rare kidney diseases. Since these new drugs have the potential to transform clinical practice and provide new hope to improve the lives of patients with kidney diseases, there is a major need to communicate the latest research in this growing area to allow widespread clinical use and achieve better therapeutic effects.

In recognition of the robust novel therapeutic strategies for the management of kidney disease, Kidney and Blood Pressure Research is launching an article collection on “Novel Drugs in the Nephrology Arena”. Authors are welcome to submit research articles and reviews describing advances in the treatment of kidney disease with a focus on new drugs for the management of CKD and rare kidney diseases. By addressing these topics, authors can contribute valuable insights on the latest therapeutic approaches for the management of kidney diseases for clinicians to use them more appropriately and achieve better-informed solutions in their clinical practice.

Please select the option “Call for Papers: Novel Drugs in the Nephrology Arena” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Nephron

Person-Centered Healthcare in Nephrology

Nephron is calling for research articles, reviews, and case studies that present novel insights into person-centered healthcare in nephrology for the "World Kidney Health" section of the journal. Person-centered healthcare is more than patient-centered healthcare in that the patient (and carers such as family members) is an equal partner in the design and co-production of kidney healthcare. Person-centered healthcare is an approach to practice established through the formation and fostering of mutual and respectful relationships between all healthcare providers, service users (patients/consumers), and others significant to them in their lives.

Topics of particular interest are:

• Person-centered care along the chronic kidney disease trajectory
• Person-centered care and its role and potential for an integrated response to health needs of people living with kidney failure
• Service delivery approaches to embedding person-centered care in kidney services
• Pilot and/or feasibility studies of person-centered care interventions for people with kidney disease/failure and/or receiving kidney replacement therapy
• Qualitative studies of patients or carers receiving person-centered care
• Facilitators and barriers to delivering person-centered care
• Value-based healthcare approaches or cost-effectiveness of delivery person-centered care in kidney services

Please select the option “Call for Papers: Person-centered Healthcare in Nephrology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Nephron supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Nephron

Genetics and Epigenetics of Renal Ciliopathies

Renal ciliopathies are a clinically and genetically heterogeneous group of disorders with widely varying manifestations, from in utero symptoms to clinically silent disease until adulthood. The group includes autosomal dominant and recessive polycystic kidney diseases, nephronophthisis, medullary cystic kidney disease, as well as less frequent cilia-related disorders.

The goal of this Call for Papers is to dedicate an article collection to emerging insights on cystic kidney disease phenotypes and the underlying genetic and epigenetic determinants. We will consider original research articles, brief reports, case reports, and review articles focusing on, but not strictly limited to, the following topics:

Topics of particular interest are:

• Identification of novel and/or complex genetic abnormalities in renal ciliopathies
• Epigenetic mechanisms in the pathogenesis of PKD
• Novel findings exploring the relation between genotype and disease phenotype
• Description of novel ciliopathy syndromes
• Cohort studies describing the impact of genetic background on the response to therapies
• In vitro and in vivo models to validate and characterize candidate ciliopathy genes and to test new therapies

Please select the option "Call for Papers: Genetics and Epigenetics of Renal Ciliopathies" when submitting your manuscript and mention this Call for Papers in your cover letter.

Nephron supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cerebrovascular Diseases

Advances in the Management of Intracranial Hemorrhage

The journal Cerebrovascular Diseases is calling for papers for an article collection entitled “Advances in the Management of Intracranial Hemorrhage” which aims to bring together recent research and review articles, as well as brief reports, focusing on, but not strictly limited to, the following topics:

• Epidemiology and Genetics of ICH
• Imaging of ICH
• Hyperacute Medical Management of ICH
• Reversal of OAC - related ICH
• ICH Recovery and Rehabilitation

Please select the option “Call for Papers: Advances in the Management of Intracranial Hemorrhage” when submitting your manuscript and mention this Call for Papers in your cover letter.

Cerebrovascular Diseases supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cerebrovascular Diseases

Frailty in Stroke

We are increasingly aware that frailty is associated with stroke risk and factors propagating this influence in the frail include:

• Increased number and severity of stroke risk factors
• Increased stroke complications and poorer stroke recovery
• Increased severity of stroke
• Decreased response to treatment

However, limited data exist on the above in certain stroke sub-types and we remain unclear as to how best to assess frailty in stroke, incorporate assessments into treatment decisions and understand some of the pathophysiological [processes involved with transition from pre-stroke frailty to post-stroke frailty.

To date, the frailty in stroke literature has been dispersed across ageing, gerontology and cerebrovascular journals – this special issue offers a unique opportunity to homogenise the science and expertise to encourage engagement from cross-specialty collaborations to advance this field.

We welcome original research articles, brief reports, protocols, review articles, and letters presenting a perspective to advance the understanding of the role of frailty in stroke. Topics of interest are, but not strictly limited to, the following:

• Frailty and stroke outcome, particularly in stroke sub-types including intracerebral haemorrhage, cerebral venous sinus thrombosis and subarachnoid haemorrhage.
• Factors influencing propagation of frailty and stroke risk.
• Pre-frailty and frailty trajectories for stroke survivors.
• Reperfusion therapies and frailty as a modifier in stroke care.
• Broader frailty considerations including cognitive, psychological and biological associations and mechanisms.

Please select the option “Call for Papers: Frailty in Stroke” when submitting your manuscript and mention this Call for Papers in your cover letter.

Cerebrovascular Diseases supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cerebrovascular Diseases

Sex and Gender Disparities in Stroke

Cerebrovascular Diseases journal is pleased to announce that it will publish papers and an article collection on “Sex and Gender Disparities in Stroke”.

Despite recent landmark achievements in stroke research and treatment, there remains a pressing need to address the sex and gender disparities associated with stroke incidence, treatment outcomes, and access to healthcare. This call for papers has a broad scope, and we invite researchers, clinicians, public health experts, and other stakeholders to submit their original research articles, brief reports, review articles, and letters presenting a perspective to deepen the understanding of sex and gender disparities in stroke. We particularly welcome submissions from low- and middle-income countries where sex-disaggregated stroke data are lacking, as well as insights into disparities faced by the LGBTQI community affected by stroke. Additionally, we value the sharing of local and regional experiences in this field and encourage proposals for evidence-based approaches to mitigate these inequalities.

Topics of interest:

• State-of-the-art reviews of the current landscape of sex and gender disparities in stroke
• Sex and gender-specific risk factors and social determinants contributing to variations in stroke epidemiology
• Preventive measures tailored to women's specific needs, including awareness of stroke, lifestyle interventions, medications, and health promotion initiatives
• Differences in timely diagnosis, access to medical treatment, use of therapeutic interventions, and access to post-stroke rehabilitation
• Sex and Gender disparities on functional recovery, quality of life, and mortality
• Sex and Gender-sensitive healthcare policies to reduce disparities in stroke prevention, treatment, and long-term care

Please select the option “Call for Papers: Sex and Gender Disparities in Stroke” when submitting your manuscript and mention this Call for Papers in your cover letter.

Cerebrovascular Diseases supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Dementia and Geriatric Cognitive Disorders

Enhancing Ethnocultural Diversity and Under-Represented Groups in Dementia Research

Alzheimer’s disease involves a multitude of risk and protective factors encompassing genetics and lived experiences. Ethnoculturally diverse individuals from under-represented groups (URGs), including Black/African American and Hispanic/Latinx individuals in the United States and globally, are disproportionally at greater risk of Alzheimer’s disease. Further, physiological ethno-racial differences are observed, such as the amyloid (A), tau (T), and neurodegeneration (N) biomarkers used in the current diagnostic criteria for Alzheimer’s disease. Despite these recognized disease heterogeneities, recruitment of under-represented groups lags in basic research, clinical trials and dementia prevention studies.

Recognizing the gap in communication that exists between minority populations and Alzheimer’s disease research community, education and outreach are a critical step in addressing these disparities. We are calling for articles to highlight studies into under-represented groups ranging from basic genetic and biomarker research to innovative strategies for successful recruitment. These studies will provide data relevant to specific populations, which when taken together, can also provide fundamental insights into the causes and treatments of dementia.

This call for articles aims to collect articles describing the latest developments in the research of URGs. We will consider original research articles, brief reports, protocols and review articles focusing on, but not strictly limited to, the following topics:

• Biomarker, neuroimaging, genomic studies of URGs
• Approaches to enhance recruitment of URGs
• Pharmacogenomic response to treatments and medications of URGs

Please select the option “Call for Papers: Under-represented groups in dementia research” when submitting your manuscript and mention this Call for Papers in your cover letter.

Dementia and Geriatric Cognitive Disorders supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Dementia and Geriatric Cognitive Disorders

Non-Pharmacological Approaches to Prevent, Intervene, and Care for People Living with Dementia

The latest meta-analyses and systematic reviews of epidemiological and clinical studies have provided compelling new evidence regarding the prevention, intervention, and care of people living with dementia. These syntheses identified modifiable factors which can impact on cognitive and physical reserve across the life course. These factors include multiple risk activities such as low education attainment, hearing loss, hypertension, obesity, depression, physical inactivity, and social isolation.

The strategies to abrogate the negative impacts of these factors are the basis for non-pharmacological approaches to reduce dementia risk, or to reduce the substantial neuropsychiatric burden. Of note, previous single-intervention failures stress the critical need for a new multimodal preventive approach where combinations of modifiable risk factors and disease mechanisms are targeted simultaneously. Further, there is increasing recognition that underserved ethnic groups have higher prevalence of modifiable risk factors than the country's majority population.

This call for articles aims to collect research articles and reviews describing the latest developments in the research and implementation of non-pharmacological approaches to reduce dementia and co-morbidities. We will consider original research articles, brief reports, protocols review articles and systematic reviews focusing on, but not strictly limited to, the following topics:

• Application of single/multi-modal non-pharmacological approaches to reduce risk or severity of dementia.
• Application of single/multi-modal non-pharmacological approaches to manage co-morbidities such as depression and other behavioural and psychological symptoms.
• Identification of the appropriate target groups and optimal timing for intervention, based on the differential impacts of biological sex or socio-ethnographic factors.

Please select the option “Call for Papers: Non-Pharmacological Approaches to Prevent, Intervene, and Care for People Living with Dementia” when submitting your manuscript and mention this Call for Papers in your cover letter.

Dementia and Geriatric Cognitive Disorders supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Dementia and Geriatric Cognitive Disorders

Harnessing Smart Technologies to Enhance Translation of Dementia Research from Bench to Bedside

The rapid improvement in smart technologies have generated a multitude of applications for dementia research and care, ranging from remote diagnosis to health delivery. Technologies include established modalities such as smartphones and tablets, which provide access to personal computing and associated capabilities. Further, wearables, smart home systems, robots, virtual reality and artificial intelligence are also enabling the development of targeted strategies to deliver care for those living with dementia.

This call for articles aims to collect articles describing the latest developments in the research and implementation of these technologies. We will consider original research articles, brief reports, protocols and review articles focusing on, but not strictly limited to, the following topics:

• Application of digital platforms to aid in remote diagnoses of neurodegeneration
• Identification of novel digital biomarkers that can be translated to remote diagnoses
• Use of smart technologies to enhance at-home care for patients

Please select the option “Call for Papers: Harnessing smart technologies to enhance translation of dementia research from bench to bedside” when submitting your manuscript and mention this Call for Papers in your cover letter.

Dementia and Geriatric Cognitive Disorders supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Developmental Neuroscience

New Insights into the Formation of Neural Circuits

The journal Developmental Neuroscience solicits papers on the mechanisms leading to physiological or aberrant neural circuit formation.

Topics covered include but are not limited to:

• Distinct neuronal subtypes and wiring specificity
• Formation of dendritic arbors and spines
• Axonal pathfinding, targeting, and branching
• Role of glial cells in circuit development
• Synaptogenesis and synapse elimination
• Aberrant circuit formation

Please select the option “Call for Papers: New insights into the formation of neural circuits” when submitting your manuscript and mention this Call for Papers in your cover letter.

Developmental Neuroscience is a Subscribe to Open (S2O) journal, aiming to achieve Open Access without cost to authors or readers. Authors submitting in 2023 can publish open access Open Access without any charges.

Developmental Neuroscience

Novel Insights on Neocortex Development

We are excited to announce a call for papers on “Novel Insights on Neocortex Development”. This call seeks to uncover and explore the latest advancements in understanding the neurodevelopment of the neocortex, a pivotal region of the brain involved in complex cognitive processes.

We welcome a wide array of research topics, including: the molecular and cellular mechanisms that influence neocortical development, the impact of genetic and environmental factors on neocortical structure and function, and the application of cutting-edge technologies and methodologies in studying neocortical maturation. Contributions that examine the implications of these findings for neurodevelopmental disorders and cognitive functions are also encouraged.

Our goal is to showcase innovative research and foster interdisciplinary discussions that bridge developmental biology, neuroscience, and clinical studies. We encourage researchers at all stages of their careers to share their most recent discoveries and theoretical insights. We look forward to your contributions and to advancing the field of neocortical development.

Please select the option “Call for Papers: Novel Insights on Neocortex Development” when submitting your manuscript and mention this Call for Papers in your cover letter.

Developmental Neuroscience is a Subscribe to Open (S2O) journal, aiming to achieve Open Access without cost to authors or readers. Authors submitting in 2024 can publish Open Access without any charges.

Developmental Neuroscience

Role of Microglia in Brain Development

The journal Developmental Neuroscience solicits papers on the role of microglia in brain development.

Topics covered include but are not limited to:

• Microglial effects on progenitor cells
• Microglial modulation of neuronal positioning and wiring
• Microglial support of vascular formation and integrity
• Synaptic pruning by microglia
• Effects of impaired microglial function on brain development

Please select the option “Call for Papers: Role of microglia in brain development” when submitting your manuscript and mention this Call for Papers in your cover letter.

Developmental Neuroscience is a Subscribe to Open (S2O) journal, aiming to achieve Open Access without cost to authors or readers. Authors submitting in 2023 can publish Open Access without any charges.

European Neurology

Sleep-Wake Disorders in Neurological Diseases

European Neurology is pleased to announce that it will publish papers for an article collection on Sleep-wake disorders in neurological diseases.

 We welcome original research articles, brief reports, review articles, and novel and relevant case reports series presenting advancements to the understanding of the role of sleep on neurological diseases. Topics of interest are, but not strictly limited to, the following: sleep-related motor disorders, insomnia, parasomnias, circadian rhythm disorders and hypersomnia/daytime sleepiness.

Please select the option “Call for Papers: Sleep-Wake Disorders in Neurological Diseases” when submitting your manuscript and mention this Call for Papers in your cover letter.

European Neurology European Neurology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Neurodegenerative Diseases

Anti-amyloid Drugs: A Therapeutical Revolution in Alzheimer’s Disease

Anti-amyloid drugs are becoming available to slow-down cognitive decline for Alzheimer’s disease, however this comes with serious medical, economic, and ethical considerations. Recent concerns about safety, particularly in patients with cerebral amyloid angiopathy and specific genotypes, also raise the question of appropriate early patient selection and exclusion. We are calling for contributions to an article collection dedicated to emerging insights on clinical and research question that may guide the future of these therapeutics in AD. We will consider original research articles, protocols, guidelines, brief reports, and review articles focusing on, but not strictly limited to, the following topics:

• Biological mechanisms of action of anti-amyloid drugs
• Epidemiological studies addressing the critical issue of patient selection
• Economic implication and healthcare system planning
• Advanced neuroimaging techniques with a specific focus on amyloid-related imaging abnormalities (ARIA)

The accepted papers will be published in an article collection in Neurodegenerative Diseases entitled “Anti-amyloid drugs: a therapeutical revolution in Alzheimer’s disease.”

Please select the option “Call for Papers: Anti-amyloid drugs: a therapeutical revolution in Alzheimer’s disease” when submitting your manuscript and mention this Call for Papers in your cover letter.

Neurodegenerative Diseases is a Transformative Journal and supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Neurodegenerative Diseases

Posture and Movement under Influence

The journal Neurodegenerative Diseases is calling for contributions for an article collection entitled “Posture and movement under influence”.

The objective of this article collection is to bring a new insight on the different factors influencing the control of posture and movement, with implications in the understanding, assessment, and treatment of neurodegenerative diseases. A particular attention will be paid to the neuro-physiological, neuro-biomechanical, and neuro-cognitive factors. We will consider reviews, research articles, brief reports, and method papers on the listed topics.

Please select the option “Call for Papers: Posture and movement under influence” when submitting your manuscript and mention this Call for Papers in your cover letter.

Neurodegenerative Diseases supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Neurodegenerative Diseases

Sex and Gender in Neurodegenerative Diseases

Neurodegenerative Diseases Journal is pleased to announce that it will publish papers and an article collection on “Sex and gender in neurodegenerative diseases”.

Sex and gender play a significant role in neurodegenerative diseases, but their impact on disease risk and mechanisms, progression, and treatment responses remains understudied. This special issue aims to highlight how sex and gender influence risk, pathophysiology, and clinical outcomes in neurodegenerative conditions including, but not limited to, Alzheimer’s disease and Parkinson’s disease. Contributions may include studies on biological and/or social determinants and risk factors, disparities in disease mechanisms and progression, and strategies for integrating these insights into clinical practice. Our goal is to promote research that advances the field and contributes towards improved prevention strategies, diagnostics, and treatment for diverse groups, with a particular interest in novel and cutting-edge research.

We welcome a wide array of submissions including original research, brief reports, protocols, review articles, and perspectives that enhance our understanding of sex and gender influences on neurodegenerative diseases. To ensure precision and reproducibility, and to prevent ambiguity or misinterpretation of 'sex' and 'gender' terms, authors should clearly define their use of these terms and the bases for their measurements (please refer to Sex and Gender Equity in Research (SAGER) guidelines and the SAGER guidelines checklist).

Submissions that employ multidisciplinary approaches and/or have a strong translational focus, bridging research and clinical practice, are especially welcome. We further encourage submissions providing insights into sex and gender disparities among ethnic minority groups, the LGBTQI community, and other under-represented populations. In addition, we value papers that focus on evidence-based approaches to mitigate health-care inequalities.

Topics of interest are, but not strictly limited to, the following::

1. State-of-the-art reviews on sex and gender disparities in neurodegenerative diseases.
2. Sex- and gender-specific risk factors and biological/social determinants contributing to risk, pathophysiology, clinical outcomes, and disease progression.
3. Sex- and gender disparities in disease mechanisms and progression.
4. Sex- and gender disparities in diagnostic processes, access to medical treatment, and use of therapeutic interventions.
5. Sex and gender disparities in mental health, well-being, and quality of life.
6. How sex and gender intersect with other identity dimensions (e.g., race, ethnicity, culture, socio-economic status) to influence clinical outcomes and quality of health care.
7. Preventive measures tailored to personalised needs related to sex and gender (and broader identity factors), including risk awareness, symptom management, lifestyle interventions, medications, and health promotion initiatives.

Please select the option “Call for Papers: Sex and gender in neurodegenerative diseases” when submitting your manuscript and mention this Call for Papers in your cover letter.

Neurodegenerative Diseases is a Transformative Journal and supports Open Access publications. Publishing in this journal will ensure authors meet a plan-S style funding mandate. In addition, corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of one of these universities/institutions.

Neuroepidemiology

Neuroepidemiology in Africa

Neuroepidemiology is calling for reviews, systematic reviews, brief reports, and research articles to be published in a special article collection entitled "Neuroepidemiology in Africa".

Potential authors are invited to submit articles of topics mentioned above that will be rapidly peer reviewed. Please mention the Call for Paper in your Cover Letter when submitting.

Please select the option “Call for Papers: Neuroepidemiology in Africa” when submitting your manuscript and mention this Call for Papers in your cover letter.

Neuroepidemiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Neuroepidemiology

Costs of Neurological Disorders

Neurological disorders have become the leading cause of deaths and disabilities combined, but their societal costs (direct and indirect) remain largely unexplored. However, knowing the costs of neurological disorders (separate disorders and all such disorders combined) on the national, regional, and global levels is of great importance for health care planning and resource allocation. We are calling for review, analytic, and methodology papers on the costs of neurological disorders (including projections of the costs in the near 20-30 years) for an article collection in Neuroepidemiology entitled “Costs of Neurological Disorders”.

Potential authors are invited to submit articles on topics mentioned above that will be rapidly peer-reviewed.

Please select the option "Call for Papers: Costs of Neurological Disorders" when submitting your manuscript and mention this Call for Papers in your cover letter.

Neuroepidemiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Neuroepidemiology

Epidemiology of Sleep Disorders in Neurology

Neuroepidemiology is calling for reviews, systematic reviews, brief reports, and research articles to be published in a special article collection entitled Epidemiology of Sleep Disorders in Neurology.

Potential authors are invited to submit articles on topics mentioned above that will be rapidly peer-reviewed.

Please select the option "Call for Paper: Epidemiology of Sleep Disorders in Neurology" when submitting your manuscript and mention this Call for Papers in your cover letter.

Neuroepidemiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Annals of Nutrition and Metabolism

Prehabilitation: Nutritional Interventions and Metabolic Mechanisms

Prehabilitation has become a very promising strategy for reducing severe complications in high-risk patients who will undergo major surgery. Focusing on nutrition and metabolism, prehabilitation includes a trimodal combination of nutrition, endurance and resistance training, and some psychological intervention for 2-6 weeks. In cancer patients, neoadjuvant therapy opens a regular time window for conditioning before surgery. Although there have been several randomized trials and meta-analyses on this topic, evidence is still limited – mainly due to considerable heterogeneity. An umbrella review found moderate evidence for functionally relevant improvement like the 6-Min Walking Distance Test. However, the evidence supporting reductions in complications, non-home discharge, and length of hospital stay were of only low to very low certainty.

According to a very recent meta-analysis, more benefits may be expected with special regard to frail and high-risk patients. Regarding the impact of prehabilitation on metabolism and immune system, data is still sparse. There is no data for fortified nutrition or enriched nutritional supplements for a longer preoperative period. Functional improvement without impact on surgical outcome also opens a debate about necessity and resources for implementation.

The goal of this article collection in Annals of Nutrition and Metabolism is to highlight recent advances and evidence concerning prehabilitation for different types of surgery and how to select appropriate patients. A special focus of “Prehabilitation” will be on nutritional interventions and metabolic mechanisms of prehabilitation.

In this special call we welcome original research, review articles, systematic reviews, and perspectives in the field of prehabilitation.

Please select the option “Call for Papers: Prehabilitation: Nutritional Interventions and Metabolic Mechanisms” when submitting your manuscript and mention this Call for Papers in your cover letter.

Annals of Nutrition and Metabolism supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Lifestyle Genomics

Open Access Journal

Precision Nutrition and Lifestyles for Managing Cardiometabolic Diseases

Cardiometabolic diseases describes a group of morbid manifestations that includes cardiovascular conditions, inflammation, type 2 diabetes, insulin resistance and fatty liver dysfunction. Lifestyle interventions are commonly the first approach to prevent and treat cardiometabolic diseases. However, it is well recognized that the responses to interventions that aim to manage cardiometabolic diseases are highly variable, with some individuals exhibiting the desired outcome and some individuals showing no response or even adverse manifestations. Understanding the basis for personalized responses is essential to develop comprehensive and dynamic nutritional and lifestyle recommendations relevant to both individuals and for population health. Precision nutrition is an emerging field that aims to characterize and integrate the genetic, epigenetic, and metagenomic factors that contribute to inter-individual variability in response to diet and lifestyle interventions. Moreover, this field also encompasses a broad perspective that considers dietary patterns, circadian rhythms, health status markers, physical activity assessment, as well as socioeconomic and psychosocial features, that can be considered as dynamic and integrative endpoints. While the application of precision nutrition and lifestyle for the management of cardiometabolic comorbidities remains in early stages, the results to date give cause for optimism and quick promising implementation. However, much research remains if we are to translate findings from basic investigative studies to clinical practice.

The overarching goal of this collection of articles is to highlight recent advances in the application of precision nutrition and lifestyle for the management of cardiometabolic diseases, including where ‘omic technologies and bioinformatic tools play relevant roles. This collection will consider new mechanistic insights as well as clinical applications related to precision nutrition and lifestyle. Additionally, articles that address the barriers and challenges facing the field, or outline the opportunities for knowledge translation, are equally appropriate.

In this Special Call, we welcome original research, review articles, systematic reviews, and perspectives in the fields of precision nutrition, lifestyle, and cardiometabolic diseases including cardiovascular disease, type 2 diabetes, fatty liver disease and obesity.

If you have any questions about this Special Call or would like to confirm the suitability of your manuscript, please email David M Mutch (Editor-in-Chief of Lifestyle Genomics).

Please select the option “Call for Papers: Precision Nutrition and Lifestyles for Managing Cardiometabolic Diseases” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Lifestyle Genomics

Open Access Journal

Preclinical Investigations to Advance Understanding of Nutrigenetic and Nutrigenomic Targets

It is now well recognized that genetic variants (i.e. single nucleotide polymorphisms and copy number variants) can influence a person’s response to specific nutrients or dietary patterns. Some genetic variants have been associated with inter-individual differences in the digestion, absorption, and metabolism of a nutrient, while other variants have been more broadly associated with disease biomarkers and health outcomes. While these variants have garnered considerable interest for those working in the field of precision nutrition, there remain significant gaps in our understanding of the underlying molecular mechanisms by which these variants influence outcomes. For example, some variants can influence gene expression through transcriptional and epigenetic mechanisms, while others can influence protein function. The use of cell culture and animal models, therefore, provides opportunities to explore the mechanisms and pathways influenced by genetic variants that are not always feasible to study directly in humans. Moreover, these model systems are also widely used to advance understanding of the broad impact of nutrients and diets on global gene expression (transcriptomics), methylation patterns (epigenetics), protein abundance (proteomics) and metabolites (metabolomics) in individual cell types and tissues.

The overarching goal of this collection of articles is to demonstrate how preclinical investigations can help advance our understanding of the molecular mechanisms through which individual nutrients and dietary patterns affect health and disease outcomes. This collection will consider in vitro (in both animal and human cells) and in vivo animal studies, but not human clinical trials. In this Special Call, we welcome original research, review articles, and perspectives related to the use and value of preclinical investigations that provide new mechanistic knowledge and insight regarding diet-gene interactions.

If you have any questions about this Special Call or would like to confirm the suitability of your manuscript, please email David M. Mutch (Editor-in-Chief of Lifestyle Genomics).

Please select the option “Call for Papers: Preclinical Investigations to Advance Understanding of Nutrigenetic and Nutrigenomic Targets” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Chemotherapy

Therapeutic Drug Monitoring in the Cancer Patient

The article collection “Therapeutic Drug Monitoring in the Cancer Patient” is intended as a forum for research or review articles on various aspects of Therapeutic Drug Monitoring (TDM) in contemporary oncology, including studies of small molecules (cytostatic/cytotoxics, tyrosine kinase inhibitors, immunomodulators), antibodies, and CAR-T cells. Screening for drug metabolism polymorphism and pharmacokinetic correlates of drug efficacy or toxicity in special populations - children, the elderly, high-risk multi-morbidity patients - would be important topics to address.

Authors should refer to the author guidelines.. The manuscript submission deadline is September 30, 2024.

Please select the option “Call for Papers: Therapeutic Drug Monitoring in the Cancer Patient” when submitting your manuscript and mention this Call for Papers in your cover letter.

Chemotherapy supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Chemotherapy

Therapeutic Drug Monitoring (TDM) in Infectious Diseases

Optimization of antimicrobial therapy is essential for the improvement of the management and clinical outcomes of patients with infections. Antimicrobial therapy plays a critical role in treating severe infections and sepsis, and it is necessary to design appropriate antimicrobial dosing based on pharmacokinetic/pharmacodynamic (PK/PD) profiles. Sepsis can alter the distribution volume and clearance of antibiotics, leading to suboptimal or excessive antibiotic concentrations that can impact patient outcomes. The Surviving Sepsis Campaign recommends optimizing dosing strategies for antimicrobials by considering PK/PD and specific drug characteristics as a best practice procedure. To achieve this, therapeutic drug monitoring (TDM) is a strategy that quantifies drug concentrations in different biological samples.

Determining the plasma concentrations of a drug in the individual patient as a reference for possible dosage correction, TDM aims to maximize drug efficacy and minimize toxicity, thereby optimizing patient outcomes. TDM is increasingly being used for antiretrovirals, antibiotics, and antifungals and demonstrated to improve the likelihood of successful clinical outcomes, especially in cases involving drug interactions, pregnancy, or impaired liver and/or kidney function. This article collection on TDM in infectious diseases aims to improve our understanding of TDM's role in infection management and the effects of TDM-guided therapy on clinical outcomes, particularly in critically ill patients.

Authors should refer to the author guidelines. The manuscript submission deadline is September 30, 2024.

Please select the option “Call for Papers: Therapeutic Drug Monitoring in Infectious Diseases” when submitting your manuscript and mention this Call for Papers in your cover letter.

Chemotherapy supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Oncology

Artificial Intelligence and Decision-Making in Oncology

Artificial intelligence (AI) has made remarkable progress in recent years, transforming how we collect data, interact with machines, and work. These changes also affect how we make decisions in clinical practice, from assessing risks to recommending treatments. We welcome original and review papers on topics related to AI and decision-making in oncology. The manuscripts will be considered for the collection "AI and Decision-Making in Oncology".

Please select the option “Call for Papers: AI and Decision-Making in Oncology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Oncology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Oncology Research and Treatment

Beyond Biology: The Crucial Role of Sex and Gender in Oncology

In the dynamic field of oncology, the influence of sex and gender remains a critical yet underexplored dimension. Historically, medical research has often overlooked these factors, leading to a one-size-fits-all approach in cancer treatment and care. However, recent advancements underscore the importance of understanding how both biological sex and sociocultural gender roles significantly influence cancer epidemiology, treatment efficacy, and patient outcomes.

Biological sex plays an undeniable role in oncology. Men and women exhibit different genetic, hormonal, and immunological profiles, which can lead to variations in e.g., cancer susceptibility and progression, pharmacodynamics and pharmacokinetics.

Gender – the roles, behaviors, and expectations society ascribes to men and women – also significantly impacts cancer care. Gender influences factors such as health-seeking behavior, access to healthcare, and adherence to treatment. For example, men are generally less likely to seek medical help or participate in preventive health screenings, potentially leading to later-stage diagnoses and poorer prognoses. Women might face gender-based disparities in the recognition and treatment of their symptoms. The importance of investigating the impact of sex and gender in oncology is twofold:

Firstly, it enables the development of more effective, personalized treatment strategies. Recognizing sex-based biological differences can guide the selection of therapeutic agents and dosing regimens, potentially improving treatment efficacy and reducing adverse effects. Secondly, understanding gender-related aspects can enhance patient care and support. Tailoring psychosocial interventions to address gender-specific needs and challenges can significantly improve patient well-being and treatment compliance.

To fully harness these benefits, a concerted effort is needed in oncological research and practice. This includes conducting sex-disaggregated research, developing gender-sensitive treatment protocols, and implementing policies that address gender disparities in healthcare access and quality. The investigation of sex and gender in oncology is not a mere academic pursuit; it is a necessity for advancing cancer care. By embracing these complexities, the medical community can move towards more personalized, effective, and equitable cancer treatment and support for all patients.

We are calling for contributions to an article collection dedicated to emerging insights on clinical and research questions that address the critical impact of sex and gender in cancer diagnosis and treatment. We will consider original research articles, brief reports, and review articles.

The accepted papers will be published in an article collection in Oncology Research and Treatment entitled “Beyond Biology: The Crucial Role of Sex and Gender in Oncology”.

Please select the option “Call for Papers: Beyond Biology: The Crucial Role of Sex and Gender in Oncology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Oncology Research and Treatment supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Oncology Research and Treatment

Cellular Immunotherapy – State of the Art and Future Developments

Advancements in cellular immunotherapy have shown promising results in the treatment of both cancer and hematological malignancies. While CAR-T therapeutics are the most advanced, development continues for non-T-cell therapies including NK-cell, dendritic-cell, stem-cell, and other myeloid-derived-cell therapies. However, there are still challenges to overcome, including the need for more suitable tumor-specific targets, overcoming short duration of CAR-T cells or CAR-NK cells, reducing high production costs, and addressing high relapse rates.

We are pleased to announce a call for papers for an article collection of Oncology Research and Treatment focusing on the latest advancements in Cellular Immunotherapy. We invite original research articles, reviews, and case studies that provide new insights into this rapidly evolving field.

Please select the option “Call for Papers: Cellular Immunotherapy – State of the Art and Future Developments” when submitting your manuscript and mention this Call for Papers in your cover letter.

Oncology Research and Treatment supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Oncology Research and Treatment

Current Treatment Concepts for Advanced Genitourinary Cancer

Supportive care is an essential component of successful cancer treatment. It provides the patients with an arsenal of resources that help them successfully navigate their cancer journey. The options range from pain control and managing adverse events to prehabilitation to nutritional counseling, social work, financial advocacy, integrative medicine, music therapy, exercise, and relaxation techniques. Connecting patients to these resources not only improves their quality of life but may also increase the efficacy of cancer treatment.

We are pleased to announce a call for papers for an article collection focused on "Supportive Care in Modern Oncology". We welcome original research, review articles, and case studies discussing all aspects of supportive care of cancer patients. We are particularly interested in manuscripts that discuss novel options, such as digital therapeutics or the implementation and evaluation of complex interventions.

Please select the option “Call for Papers: Supportive Care - Essential for Modern Oncology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Oncology Research and Treatment supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Oncology Research and Treatment

Liquid Biopsy in Diagnosis and Treatment Monitoring of Solid Tumors

The emergence of liquid biopsy as a promising tool in the diagnosis and monitoring of solid tumors has revolutionized the landscape of oncology. Current research in the field of liquid biopsy in solid tumors includes:

• Exploration of the technical challenges and advancements in the detection of circulating tumor biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and extracellular vesicles (EVs); from sample collection to data interpretation.
• Investigations into sensitivity, specificity, and reliability of various liquid biopsy techniques and comparative studies evaluating the efficacy of liquid biopsy as a standalone diagnostic tool or its complementarity to traditional tissue biopsies.
• Discussions on the clinical implications, advantages, and limitations of integrating liquid biopsy into routine diagnostic protocols.
• Exploration of quantitative approaches to assess minimal residual disease (MRD) using liquid biopsy and its implications for treatment decision-making.
• The potential of liquid biopsy in early cancer detection and screening, with a focus on methylation panels.
• The use of liquid biopsy in various solid tumors, including, but not limited to, early and metastatic breast cancer, colorectal cancer, and bladder cancer.

We are calling for contributions to an article collection dedicated to emerging insights on clinical and research questions that address the critical impact of liquid biopsy in diagnosis and treatment of solid tumors. We will consider original research articles, brief reports, and review articles. Accepted articles will be published in an article collection in Oncology Research and Treatment entitled “Liquid Biopsy in Diagnosis and Treatment Monitoring of Solid Tumors”.

Please select the option “Call for Papers: Liquid Biopsy in Diagnosis and Treatment Monitoring of Solid Tumors” when submitting your manuscript and mention this Call for Papers in your cover letter.

Oncology Research and Treatment supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Oncology Research and Treatment

Supportive Care - Essential for Modern Oncology

In the dynamic field of oncology, the influence of sex and gender remains a critical yet underexplored dimension. Historically, medical research has often overlooked these factors, leading to a one-size-fits-all approach in cancer treatment and care. However, recent advancements underscore the importance of understanding how both biological sex and sociocultural gender roles significantly influence cancer epidemiology, treatment efficacy, and patient outcomes.

Biological sex plays an undeniable role in oncology. Men and women exhibit different genetic, hormonal, and immunological profiles, which can lead to variations in e.g., cancer susceptibility and progression, pharmacodynamics and pharmacokinetics.

Gender – the roles, behaviors, and expectations society ascribes to men and women – also significantly impacts cancer care. Gender influences factors such as health-seeking behavior, access to healthcare, and adherence to treatment. For example, men are generally less likely to seek medical help or participate in preventive health screenings, potentially leading to later-stage diagnoses and poorer prognoses. Women might face gender-based disparities in the recognition and treatment of their symptoms. The importance of investigating the impact of sex and gender in oncology is twofold:

Firstly, it enables the development of more effective, personalized treatment strategies. Recognizing sex-based biological differences can guide the selection of therapeutic agents and dosing regimens, potentially improving treatment efficacy and reducing adverse effects. Secondly, understanding gender-related aspects can enhance patient care and support. Tailoring psychosocial interventions to address gender-specific needs and challenges can significantly improve patient well-being and treatment compliance.

To fully harness these benefits, a concerted effort is needed in oncological research and practice. This includes conducting sex-disaggregated research, developing gender-sensitive treatment protocols, and implementing policies that address gender disparities in healthcare access and quality. The investigation of sex and gender in oncology is not a mere academic pursuit; it is a necessity for advancing cancer care. By embracing these complexities, the medical community can move towards more personalized, effective, and equitable cancer treatment and support for all patients.

We are calling for contributions to an article collection dedicated to emerging insights on clinical and research questions that address the critical impact of sex and gender in cancer diagnosis and treatment. We will consider original research articles, brief reports, and review articles.

The accepted papers will be published in an article collection in Oncology Research and Treatment entitled “Beyond Biology: The Crucial Role of Sex and Gender in Oncology”.

Please select the option “Call for Papers: Beyond Biology: The Crucial Role of Sex and Gender in Oncology” when submitting your manuscript and mention this Call for Papers in your cover letter.

Oncology Research and Treatment supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Cells Tissues Organs

Early Career Researchers in Developmental Biology, Stem Cell Research, and Tissue Engineering

Cells Tissues Organs, founded in 1945, represents Karger’s focus on developmental biology, stem cell research, tissue engineering, in vitro systems, and regenerative biology. The journal is dedicated to publishing leading research and is pleased to support researchers in these fields.

In line with our established commitment to support the next generation of scientists, we are pleased to announce an article collection dedicated to Early Career Researchers (ECRs). The collection aims to highlight and promote leading research of emerging scholars in our field.

We invite original research and review articles that contribute significantly to the journal’s scope and authors may submit via one of three of the journal’s sections (Development Biology, Stem Cells, or Tissue Engineering).

The call is open exclusively to ECRs who meet the following criteria:

• Must be the first author or last (senior) author of the submitted manuscript and act as corresponding author.
• Be independent researchers overseeing a funding project or running their own laboratory.
• If in a tenure track system or not, they should be within 5 years of becoming independent.

ECRs must submit a cover letter that details their eligibility. Submissions will be screened by the editors for scope and eligibility.

Please select the option “Call for Papers: Early Career Researchers in Developmental Biology, Stem Cell Research, and Tissue Engineering” when submitting your manuscript and mention this Call for Papers in your cover letter.

Cells Tissues Organs supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Pathobiology

Digital Diagnostic Techniques

With this online article collection, Pathobiology welcomes submissions that address the latest research and advancements in digital technologies as related to the field of pathobiology.

As new technologies continue to shape the world of diagnostics, thereby improving patient outcomes, this collection brings together papers that focus on the biological bases of disease and ongoing fast-paced developments of these digital technologies.

Submissions to the collection are welcome on a wide range of topics that might include the development and application of artificial intelligence, machine learning in diagnostics, algorithms for lesion interpretation, digital imaging techniques, monitoring and screening, and the challenges of implementing digital technologies. As part of the journal’s aim to act as a bridge between basic biomedical research and clinical medicine, submissions may cover areas including pathology, oncology, microbiology, cell and molecular biology, and immunology.

We seek original research articles and comprehensive reviews that advance our understanding of the development and practical applications of digital technology to further understand the underlying mechanisms of human disease.

Please select the option “Call for Papers: Digital Diagnostic Techniques” when submitting your manuscript and mention this Call for Papers in your cover letter.

Pathobiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Pathobiology

Pathobiology and Infectious Diseases

Pathobiology is pleased to announce this call for papers for an online article collection on pathobiology and infectious diseases.

This collection is inspired by the importance of our recent special issue ‘Pathology as a Key to Understand Tackle COVID-19’. With this new collection, we aim to promote further research into complex mechanisms of infectious diseases, as well as public health implications.

We welcome original research articles and comprehensive reviews that offer new perspectives on a range of topics that may include the molecular and cellular basis of pathogens, the development and spread of infectious diseases, and advances in diagnosis and treatment. These suggestions are not exhaustive, and Pathobiology is pleased to welcome submissions that cover the field of pathobiology as it pertains to infectious diseases.

Please select the option “Call for Papers: Pathobiology and Infectious Diseases” when submitting your manuscript and mention this Call for Papers in your cover letter.

Pathobiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Complex Psychiatry

Biology, Genomics and Epidemiology of Mental Health Problems Related to COVID-19

The Complex Psychiatry journal aims to bring together in this article collection research articles, review articles, as well as brief reports that focus on furthering our understanding of the biology, genomics, and epidemiology of mental health problems related to COVID-19. Despite an increasing number of COVID-19 articles published since the beginning of the pandemic, we believe that there is still a gap in knowledge regarding the genetic epidemiology of mental health in this context, which this article collection aims to address.

Topics of particular interest are:

• Studies of the causal relationships of COVID-19 traits and psychiatric traits
• Epidemiology of COVID-19 with respect to psychiatric illness
• Genome-wide studies of comorbidities involving COVID-19 and mental health
• Pleiotropy analyses regarding COVID-19 and psychiatric traits

Please select the option “Call for Papers: Biology, Genomics and Epidemiology of Mental Health Problems Related to COVID-19” when submitting your manuscript and mention this Call for Papers in your cover letter.

Complex Psychiatry supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Complex Psychiatry

Genomics, Electronic Health Records, and Artificial Intelligence in the context of Precision Psychiatry

In recent years, genomic research and Big Data Analytics have made major advancements leading to new research directions and opening new possibilities to develop tools to bring precision medicine to patients. In line with its goal, Complex Psychiatry is launching a Call for Papers for its next article collection on “Genomics, Electronic Health Records, and Artificial Intelligence in the Context of Precision Psychiatry”. This collection aims to provide different research and clinical perspectives on ongoing efforts to develop and implement Precision Psychiatry in diverse clinical populations. We are particularly interested in research and review articles that focus on different areas such as:

• Developing and implementing polygenic risk scores in clinical settings
• Leveraging electronic health records to dissect the heterogeneity of psychiatric disorders
• Applying Artificial Intelligence to refine psychiatric diagnostic criteria
• Health equity and precision psychiatry
• Integrating clinical and biological factors to stratify psychopathology risk
• Collaborative studies to implement Precision Psychiatry

Please select the option “Call for Papers: Genomics, Electronic Health Records, and Artificial Intelligence in the context of Precision Psychiatry” when submitting your manuscript and mention this Call for Papers in your cover letter.

Complex Psychiatry supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Human Development

New Ideas in the Field of Human Development

Human Development welcomes all manner of conceptual articles - both theoretical and metatheoretical - related to the study of development. With each methodological and technological innovation in developmental science arrives both new conceptual confusions and opportunities for achieving new levels of conceptual clarity in the discipline. We enthusiastically call for manuscripts that identify and resolve such conceptual confusions, both in theory and method, as well as manuscripts that advance longstanding efforts to elucidate the metatheoretical assumptions underlying the study of development.

We would also like to especially encourage conceptual analysis and advancement related to the following topics:

• Current epistemologies in the study of development
• Developmental relations between so-called “higher” (e.g., executive function) and “lower” (e.g., sensorimotor sense-making) psychological processes
• Less well represented areas within developmental science such as the development of imagination and development in adulthood and older adults

Please select the option “Call for Papers: New Ideas in the Field of Human Development” when submitting your manuscript and mention this Call for Papers in your cover letter.

Human Development supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Neuropsychobiology

Exploring Lithium: Innovations and Challenges in Psychiatry and Beyond

The Neuropsychobiology journal aims to provide a comprehensive overview of lithium’s journey over the past fifty years, as well as present and discuss current challenges and future improvements. The goal is to highlight both the scientific advancements, and the practical hurdles associated with this remarkable element.

Lithium has been a cornerstone in the treatment of bipolar disorder since its discovery in the late 1940. Over the past fifty years, lithium has remained a gold standard in psychiatric medicine due to its ability to reduce the frequency and severity of manic and depressive episodes. However, lithium therapy patients often require regular blood tests to monitor lithium levels due to its narrow therapeutic window. Additionally, long-term use can lead to side effects such as kidney and thyroid issues. Research continues to explore ways to enhance lithium’s efficacy and safety.

Topics of particular interest for the article collection on ‘Exploring Lithium in Psychiatry and Beyond’ are:

• Mechanisms of action
• Side Effects and management, including improvement of patient compliance
• Clinical innovations, including innovations in drug delivery systems
• Neurobiological background

Please select the option “Call for Papers: Exploring Lithium in Psychiatry and Beyond” when submitting your manuscript and mention this Call for Papers in your cover letter.

Neuropsychobiology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Psychopathology

A Mechanistic Approach to Psychotherapy

Despite the improvement of psychotherapy methods over the last decades, there remains considerable opportunity to improve treatment outcomes. A limited understanding of the psychological and biological mechanisms of action through which change in psychotherapy occurs impedes the personalization of psychotherapy. A mechanism-based approach moves beyond specific disorders and focuses on the functional mechanisms needed to alleviate symptoms and enhance mental well-being. A greater understanding of the mechanisms of change would contribute to advancing more effective and efficient treatment. Further, understanding the psychological and biological mechanisms could contribute to developing a coherent set of evidence-based core processes; these may be theory-based or modelled at an idiographic level and then extended to nomothetic generalizations using machine learning analyses. These models are essential since hypothesis-testing longitudinal designs are critical to understanding the mechanisms of change. An advantage of a mechanism-based approach to psychotherapy is that it is not limited to a single theory or a single school of psychotherapy. It provides a more sophisticated understanding of change, which can lead to more effective interventions that incorporate various pertinent information such as a patient´s social learning history, relationship patterns, current symptoms and everyday functioning.

Subtopics:

Each original research article will present previously unpublished data:

• on one (or several) specific changing variable(s) either of a psychological or biological nature, either related to the patient or the therapeutic relationship
• idiographic work increasing the understanding of change processes through data based on session protocols or a moment-by-moment basis in everyday life
• that enables predictive modelling of psychotherapy response and course and, thus, individualized treatment.
• dedicated to personalization of psychotherapy
• that minimizes the gap between research and practice.

or a systematic or narrative review of data:

• dedicated to elucidating the central components, the mediators and moderators of change
• based on integrative approaches to overcome the traditional boundaries of psychotherapy schools
• that aim at individualized approaches to psychotherapy

Please select the option “Call for Papers: A mechanistic approach to psychotherapy’” when submitting your manuscript and mention this Call for Papers in your cover letter.

Psychopathology supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Public Health Genomics

Open Access Journal

Applying A Public Health Lens on Gene Therapy: “Curing” Sickle Cell Disease & Beyond

Public Health Genomics publishes leading edge research and evidence-based practice at the intersection of genomic discovery and public health. Gene therapy is being lauded as the fastest growing area of innovation in genome discovery.¹ Gene therapies are treatments that edit the individual’s genome to add, remove, or otherwise modify genetic material that affects gene expression.² These therapies are experiencing a period of rapid evolvement. As of December 2022, 13 gene therapies have been approved in the U.S., 16 in the European Union and 9 in Switzerland.¹ Realizing the potential to cure conditions that until now were considered incurable, presents opportunities and challenges particularly when considering population-wide dissemination of these therapies.

For example, SCD is the most common monogenic disease in the world. While gene therapy specific to SCD presents challenges for population dissemination globally, any of the emerging gene therapies will raise similar questions concerning: required communication (e.g., informed consent, optimistic bias about outcomes), access (e.g., cost of therapy), ethical/legal (e.g., consent), partner engagement (e.g., who and how), and generating an evidence base for dissemination of best practices (e.g., inclusion/exclusion criteria). Moreover, for sickle cell disease (SCD) in particular, but other conditions as well, opportunities and challenges will be layered with particular social, cultural, historical, and geographical contexts. ^3,4

To that end, we are launching a call for manuscripts with the theme “Applying a Public Health Lens on Gene Therapy: “Curing” Sickle Cell Disease & Beyond” to be featured in a special collection. The goal is to highlight empirical, interventional, conceptual, ethical, and policy-based research being conducted to anticipate and address challenges of population dissemination of gene therapy to maximize public health benefit. Appropriate submissions for this article collection include but are not limited to the following questions:

• What work is being done that exemplifies best practices for gene therapy globally (e.g., testing of gene therapy care provision that is sustainable and scalable)?
• What actions are being taken to ensure that gene therapy is equitably accessible to all populations (e.g., public communications, public engagement, care delivery model)?
• What governance policies, capacity-building measures, and standards of care will be needed to ensure equitable access to gene therapy?
• How might existing public health programs (e.g., newborn screening) be capitalized on to ensure equitable access to gene therapy advances?
• What study designs and methods will be needed to develop an evidence base to guide implementation of gene therapy to populations globally?
• What type of institutional models might be designed to address the levels of support needed by the sickle cell population to access gene therapy?
• How are ethical, legal, and social implications (ELSI) being addressed in the development and implementation of gene therapies for sickle cell disease.

Please select the option “Applying A Public Health Lens on Gene Therapy: “Curing” Sickle Cell Disease & Beyond” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Public Health Genomics

Open Access Journal

Proactive Implementation in Translational Genomics

Genomics has progressed rapidly over the last 20 years since the first human genome was sequenced. Despite exciting genetic discoveries, implementation of genomic medicine into routine clinical practice remains challenging. This step is essential if genomics is to fulfil its promised potential and impact on patient experience and care.

To date there has been a wide range of interesting descriptive papers in the literature on the implementation of genomics into clinical practice. There is now an urgent need to examine investigations of implementation strategies that support adoption of clinical genomics. This special article collection calls for research articles, reviews and brief reports on implementation research across the translational spectrum, with an emphasis on active implementation, both in research and practice, across all areas of clinical genomics including rare disease, rare cancers, public health, precision medicine, cancer, mainstream such as cardiac care or diabetes. Appropriate submissions for this special edition include but are not limited to the following areas:

• Studies investigating and enhancing a reduction in inequity in implementation of genomics
• The use of innovative implementation science methodological approaches including novel study designs
• Cross disciplinary studies where implementation science is combined and complemented by other research disciplines
• Investigations testing implementation strategies to enhance implementation outcomes e.g., acceptability, feasibility and adoption
• Collaborative implementation science studies including strong consumer involvement
• Studies that adopt transferable learning from one clinical area or geographical area into clinical genomics or another setting
• The use of technology including AI to enhance implementation
• Approaches trialed to accelerate implementation science endeavors while retaining a robust and rigorous methodology
• Reports on studies centered on scaling up or sustainability of clinical genomics

Please select the option “Call for Papers: Active Implementation in Translational Genomics” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Public Health Genomics

Open Access Journal

Future Forecasting for Research and Practice in the Public Health Translation of Genomic Discovery

Public Health Genomics publishes rigorous research and evidence-based practice at the intersection of genomic discovery and public health. Under the leadership of the new Editor-in-Chief, Colleen M. McBride, the journal is calling for perspective pieces with the theme “Future forecasting for research and practice in the public health translation of genomic discovery” to be featured in a special collection highlighting the current breadth of research and practice opportunities for genomics to have a positive public health benefit. Submissions include but are not limited to the following questions:

• What innovations — in communications, community engagement, implementation, health care delivery, and public policy — are needed to expand the reach of genomic discovery to populations?
• How can we develop a sustainable workforce to ensure just access to evidence-based genomic applications?
• How can we foster the transdisciplinary collaborations needed for translational research aiming to integrate genomics into existing public health programs (e.g., expertise in social determinants of health, basic science, health promotion, population screening, big data collection)?
• What work is being done that exemplifies where the field needs to go to ensure health benefits population-wide and globally (e.g., testing of genomics-informed health interventions that are sustainable and scaleable)?
• What ongoing policies and legal reforms will be needed to ensure equitable access to evidence-based genomic applications?
• How might barriers to population-wide genetic risk assessment (e.g., newborn screening, family history, genetic counseling, and testing) be addressed to ensure equitable access to genomic advances?
• What study designs and methods will be needed to develop an evidence base to guide the translation and implementation of genomics to public health

Please select the option “Call for Papers: Future forecasting for research and practice in the public health translation of genomic discovery” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Saudi Journal of Health Systems Research

Open Access Journal

Generative Artificial Intelligence in Healthcare

The Saudi Journal of Health Systems Research is issuing a call for paper to an online collection entitled Generative Artificial Intelligence in Healthcare.

Generative Artificial Intelligence (GAI) is revolutionizing healthcare. Introducing GAI in healthcare can lead to more efficient, accurate, and personalised medical care, ultimately improving both economic outcomes and patient experiences.

Articles discussing topics related to Diagnostic Analysis, Personalised Treatment Plans and Medicine, Telemedicine and Patient Virtual Assistants, Predictive and Preventive Care Analytics, Patient Health Monitoring, Operational Efficiency Tools and Continuous Learning Tools are welcome.

Please select the option “Generative Artificial Intelligence in Healthcare” when submitting your manuscript and mention this Call for Papers in your cover letter.

There is no publication cost in this journal.

Saudi Journal of Health Systems Research

Open Access Journal

Healthcare Sustainability and Economic Challenges

The Saudi Journal of Health Systems Research is issuing a call for paper to an online collection entitled Healthcare Sustainability and Economics.

A Sustainable Healthcare System requires a multifaceted approach, combining cost management, revenue optimization, technological integration, workforce efficiency, supportive policies, and proactive health management. This collection aims to highlight the challenges in this field and provide a reference tool to healthcare providers and policy makers to continue to provide high-quality care for future generations.

Please select the option “Healthcare Sustainability and Economics” when submitting your manuscript and mention this Call for Papers in your cover letter.

There is no publication cost in this journal.

European Surgical Research

Open Access Journal

Gut Microbiome and Bariatric Surgery

Human gut microbiota has received considerable interest in the last few decades, but it has been only partly understood in its function to maintain both gut physiology and health as well as to induce and to even propagate many diseases. Several factors, such as diet, age, host genetics, antibiotics, geographics and lifestyle, are shaping gastrointestinal microbiota composition, either in a useful or harmful way. Alterations of the complex symbiosis between the human body and its microbiome are accused to contribute to the pathophysiology of a variety of diseases. Among them, metabolic diseases, such as diabetes and obesity, are clearly linked to dysbiosis of gut microbiota. There is upcoming evidence that bariatric surgery as therapeutic strategy to treat morbid obesity might have the potential to rebalance the intestinal ecosystem. Here, we like to encourage you to submit your high-quality scientific work on the theme “gut microbiome and bariatric surgery”.

Please select the option “Call for Papers: Gut Microbiome and Bariatric Surgery” when submitting your manuscript and mention this Call for Papers in your cover letter.

Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.

Gynecologic and Obstetric Investigation

Endometriosis: from Bench to Bedside

Gynecologic and Obstetric Investigation is issuing a call for papers for a collection of papers representing insights into the latest research in Endometriosis.

The collection aims to bring insights into the recent research and innovation in the diagnosis and treatment of Endometriosis related topics. The disease poses an increased risk of adverse pregnancy outcomes calling for ongoing research in the topic.

We welcome original research, reviews, and case reports.

The submission deadline is August 30, 2024. Articles accepted for publication after successfully completing peer-review will appear as online first.

Please select the option “Call for Papers: Endometriosis – from Bench to Bedside” when submitting your manuscript and mention this Call for Papers in your cover letter.

Gynecologic and Obstetric Investigation is a Transformative Journal and supports Open Access publications. Publishing in this journal will ensure authors meet a plan-S style funding mandate. In addition, corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of one of these universities/institutions.